FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pierre Karakiewicz

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Prostate Specific Antigen

Co-author Network

Publications

TOP 3
Firas Abdollah; Alberto Briganti; Giorgio Gandaglia; Claudio Jeldres; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Maria Passoni; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Rodolphe Thuret; Zhe Tian; Maxine Sun
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.
Ahmed Alasker; Marco Bianchi; Nawar Hanna; Jens Hansen; Salima Ismail; Malek Meskawi; Paul Perrotte; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma.
Quoc-Dien Trinh; Kevin C Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pierre Karakiewicz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Firas Abdollah; Alberto Briganti; Giorgio Gandaglia; Claudio Jeldres; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Maria Passoni; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Rodolphe Thuret; Zhe Tian; Maxine Sun
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.
Cancer epidemiology 2013;37(3):219-25.
2013: Ahmed Alasker; Marco Bianchi; Nawar Hanna; Jens Hansen; Salima Ismail; Malek Meskawi; Paul Perrotte; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma.
Cancer treatment reviews 2013;39(4):388-401.
2013: Quoc-Dien Trinh; Kevin C Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy.
Annals of surgical oncology 2013;20(6):2096-102.
2013: Firas Abdollah; Marco Bianchi; Umberto Capitanio; Cesare Cozzarini; Nadia Di Muzio; Claudio Fiorino; Nicola Fossati; Andrea Gallina; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Maria Passoni; Patrizio Rigatti; Nazareno Suardi; Maxine Sun; Alberto Briganti
Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis.
European urology 2013;63(6):998-1008.
2013: Quoc-Dien Trinh; Zhe Tian; Firas Abdollah; Marco Bianchi; Jens Hansen; Pierre I Karakiewicz; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun
In-hospital mortality and failure to rescue after cytoreductive nephrectomy.
European urology 2013;63(6):1107-14.
2013: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Christopher G Wood; evanguelos xylinas; Marko Babjuk; Eugene K Cha; Felix K Chun; Behfar Ehdaie; Margit Fisch; Helena Furberg; Pierre I Karakiewicz; Yair Lotan; Vitaly Margulis; Kazumasa Matsumoto; Armin Pycha; Jay D Raman
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
European urology 2013;63(6):1082-90.
2013: evanguelos xylinas; Marc Zerbib; Marko Babjuk; Antonin Brisuda; Talia Faison; Yves Fradet; David A Green; Pierre I Karakiewicz; Luis A Kluth; Richard K Lee; Yair Lotan; Armin Pycha; Michael Rink; Brian D Robinson; Douglas S Scherr; Shahrokh F Shariat
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
European journal of cancer (Oxford, England : 1990) 2013;49(8):1889-97.
2013: Maxine Sun; Marco Bianchi; Pierre I Karakiewicz; Quoc-Dien Trinh
Reply to Georgios Papadopoulos, Georgios Stathouros and Konstantinos Doumas' Letter to the editor Re: Maxine Sun, Marco Bianchi, Jens Hansen, et al. Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. Eur Urol 2012;62:696-703.
European urology 2013;63(5):e65-6.
2013: Firas Abdollah; Marco Bianchi; Renzo Colombo; Andrea Gallina; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Passoni; Patrizio Rigatti; Andrea Salonia; Nazareno Suardi; Maxine Sun; Manuela Tutolo; Alberto Briganti
A novel tool to assess the risk of urinary incontinence after nerve-sparing radical prostatectomy.
BJU international 2013;111(6):905-13.
2013: Firas Abdollah; Alberto Briganti; Pierre I Karakiewicz; Francesco Montorsi; Maxine Sun
Response to Re: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis.
International journal of urology : official journal of the Japanese Urological Association 2013;20(5):548-9.
2013: Morgan Rouprêt; François Rozet; Thomas Seisen; Shahrokh F Shariat; Thomas J Walton; Christopher G Wood; evanguelos xylinas; David R Yates; Richard Zigeuner; Karim Bensalah; Christian Bolenz; Pierre Colin; Olivier Cussenot; Harun Fajkovic; Hans-Martin Fritsche; Vincent Hupertan; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Vitaly Margulis; Juan I Martinez-Salamanca; Francesco Montorsi; Giacomo Novara; Adil Ouzzane; Jay D Raman; Mesut Remzi
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
The Journal of urology 2013;189(5):1662-9.
2013: Wassim Kassouf; Seth P Lerner; Yair Lotan; Giacomo Novara; Arthur I Sagalowsky; Mark P Schoenberg; Shahrokh F Shariat; Armen Aprikian; Patrick J Bastian; Colin P N Dinney; Vincenzo Ficarra; Yves Fradet; Hans Martin Fritsche; Jonathan I Izawa; Ashish M Kamat; Pierre I Karakiewicz; Robert S Svatek; Derya Tilki; Eila C Skinner
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
Urologic oncology 2013;31(4):480-6.
2013: Maxine Sun; Quoc-Dien Trinh; Malek Meskawi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Jens Hansen; Pierre I Karakiewicz
An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma.
Therapeutic advances in urology 2013;5(2):121-8.
2013: Bobby B Najari; Michael Rink; Douglas S Scherr; Peter N Schlegel; Ridwan Shabsigh; Pierre I Karakiewicz; Philip S Li; Siegfried Meryn; Shahrokh F Shariat
Sex disparities in cancer mortality: the risks of being a man in the United States.
The Journal of urology 2013;189(4):1470-4.
2013: Jesse D Sammon; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Marco Bianchi; Khurshid R Ghani; Jim C Hu; Pierre I Karakiewicz; Mani Menon; James O Peabody; Paul Perrotte; Praful Ravi; Quoc-Dien Trinh
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach.
The Journal of urology 2013;189(4):1289-94.
2013: Rodolphe Thuret; Jean-Jacques Patard; Shahrokh F Shariat; Maxine Sun; Firas Abdollah; Lars Budaus; Jacques Guiter; François Iborra; Pierre I Karakiewicz
Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.
BJU international 2013;111(4 Pt B):E174-9.
2013: Firas Abdollah; Alberto Briganti; Al'a Abdo; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines.
International journal of urology : official journal of the Japanese Urological Association 2013;20(4):405-10.
2013: Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Jens Hansen; Giovanni Lughezzani; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
International journal of urology : official journal of the Japanese Urological Association 2013;20(4):372-80.
2013: David A Green; Pierre I Karakiewicz; Surena F Matin; Michael Rink; Morgan Roupret; Douglas S Scherr; Arnulf Stenzl; evanguelos xylinas; Shahrokh F Shariat
Urothelial carcinoma of the bladder and the upper tract: disparate twins.
The Journal of urology 2013;189(4):1214-21.
2013: Alberto Briganti; Felix K-H Chun; Bruno Frea; Detlef Frohenberg; Simone Giona; Massimiliano Di Marco; Markus Graefen; R Jeffrey Karnes; Steven Joniau; Pierre I Karakiewicz; Burkhard Kneitz; Giansilvio Marchioro; Francesco Montorsi; Martin Spahn; Maxine Sun; Hein Van Poppel; Firas Abdollah; Marco Bianchi
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
European urology 2013;63(4):693-701.
2013: Michael Rink; Brian D Robinson; Douglas S Scherr; evanguelos xylinas; Emily C Zabor; Marko Babjuk; Felix K Chun; Helena Furberg; Pierre I Karakiewicz; Yair Lotan; Francesco Montorsi; Giacomo Novara; Armin Pycha; Shahrokh F Shariat
Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.
European urology 2013;63(4):724-32.
2013: evanguelos xylinas; Marc Zerbib; Robert S Svatek; Derya Tilki; Quoc D Trinh; Joual Abdennabi; Marko Babjuk; Thomas Clozel; Hans-Martin Fritsche; David A Green; Bertrand Guillonneau; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Francesco Montorsi; Giacomo Novara; Michael Rink; Douglas S Scherr; Shahrokh F Shariat
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
Annals of surgical oncology 2013;20(3):1027-34.
2013: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Daniel D Sjoberg; Scott T Tagawa; Derya Tilki; Quoc-Dien Trinh; evanguelos xylinas; Atiqullah Aziz; Marko Babjuk; Jack Baniel; Patrick J Bastian; Antonin Brisuda; Eugene K Cha; Felix K Chun; Vincenzo Ficarra; Hans-Martin Fritsche; Paolo Gontero; David A Green; Jens Hansen; Pierre I Karakiewicz; Matthew Kent; Daniel J Lee; Yair Lotan; Roy Mano; Giacomo Novara; Armin Pycha
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
BJU international 2013;111(3 Pt B):E30-6.
2013: David A Green; Jens Hansen; Pierre I Karakiewicz; Michael Rink; Brian Robinson; Douglas S Scherr; Eugene K Cha; Felix K Chun; Margit Fisch; Scott Tagawa; Zhe Tian; Shahrokh F Shariat
Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
BJU international 2013;111(3):404-11.
2013: evanguelos xylinas; Marc Zerbib; Evi Comploj; Talia Faison; Mithat Gonen; Bertrand Guillonneau; Pierre I Karakiewicz; Yair Lotan; Vitaly Margulis; Francesco Montorsi; Giacomo Novara; Armin Pycha; Jay D Raman; Michael Rink; Douglas S Scherr; Christian Seitz; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Alon Z Weizer
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
The Journal of urology 2013;189(2):468-73.
2013: Harun Fajkovic; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Vitaly Margulis; Francesco Montorsi; Giacomo Novara; Wolfgang Otto; Armin Pycha; Jay D Raman; Michael Rink; Morgan Roupret; Douglas S Scherr; Christian Seitz; Shiro Baba; Karim Bensalah; Christian Bolenz; Joaquin Carballido; Eugene K Cha; Allison Dunning; Guru Sonpavde; Quoc-Dien Trinh; Thomas J Walton; evanguelos xylinas; Richard Zigeuner; Shahrokh F Shariat
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.
World journal of urology 2013;31(1):5-11.
2013: evanguelos xylinas; Pierre I Karakiewicz; Luis Kluth; Sibani Mangal; Morgan Roupret; Shahrokh F Shariat
Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma.
World journal of urology 2013;31(1):31-6.
2013: Shahrokh F Shariat; Guru Sonpavde; Robert S Svatek; Scott T Tagawa; Quoc-Dien Trinh; evanguelos xylinas; Marko Babjuk; Eugene K Cha; fianceeyi chun; Siamak Daneshmand; Behfar Ehdaie; Harun Fajkovic; Hans-Martin Fritsche; Abdennabi Joual; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Axel S Merseburger; Giacomo Novara; Michael Rink; Douglas S Scherr; Mithat Gonen
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
European urology 2013;63(2):371-8.
2013: Thomas F Chromecki; Siamak Daneshmand; Matthieu Durand; Behfar Ehdaie; Harun Fajkovic; Hans-Martin Fritsche; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Giacomo Novara; Karl Pummer; Michael Rink; Marko Babjuk; Patrick J Bastian; Antonin Brisuda; Maximilian Burger; Eugene K Cha; Robert S Svatek; Derya Tilki; Shahrokh F Shariat
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
BJU international 2013;111(2):249-55.
2013: Rodolphe Thuret; Firas Abdollah; Lars Budaus; Jacques Guiter; François Iborra; Daniel Liberman; Jean-Jacques Patard; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Pierre I Karakiewicz
A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis.
Cancer causes & control : CCC 2013;24(1):71-9.
2013: Ashish M Kamat; Peter E Clark; Michael Droller; Jason R Gee; Nicholas Hegarty; Paul K Hegarty; Lawrence C Jenkins; Yair Lotan; Bernd J Schmitz-Dräger; Shahrokh F Shariat; Robert S Svatek; Bas W G van Rhijn; evanguelos xylinas; Pierre I Karakiewicz
ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers.
European urology 2013;63(1):4-15.
2013: Jens Hansen; Pierre I Karakiewicz; Luis A Kluth; Michael Rink; Shahrokh F Shariat; Thomas Steuber; Zhe Tian; Sascha A Ahyai; Marco Bianchi; Alberto Briganti; Margit Fisch; Markus Graefen; Felix K-H Chun
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
The Prostate 2013;73(2):211-8.
2013: Michael Rink; Douglas S Scherr; Robert S Svatek; Scott T Tagawa; Derya Tilki; evanguelos xylinas; Marko Babjuk; Patrick J Bastian; Eugene K Cha; fianceeyi chun; Evi Comploj; Roland Dahlem; Siamak Daneshmand; Talia Faison; Hans-Martin Fritsche; David A Green; Jens Hansen; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Giacomo Novara; Armin Pycha; Shahrokh F Shariat
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
BJU international 2013;111(1):74-84.
2013: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Nawar Hanna; Jens Hansen; Pierre I Karakiewicz
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.
BJU international 2013;111(1):67-73.
2012: Michael Rink; Douglas S Scherr; Maxine Sun; evanguelos xylinas; Joual Abdennabi; Marko Babjuk; fianceeyi chun; Evi Comploj; Harun Fajkovic; Margit Fisch; Jens Hansen; Pierre I Karakiewicz; Wolfgang Loidl; Yair Lotan; Armin Pycha; Shahrokh F Shariat
Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.
The Journal of urology 2012;188(6):2120-7.
2012: Michael Rink; evanguelos xylinas; Marko Babjuk; Roland Dahlem; Pierre I Karakiewicz; Giacomo Novara; Armin Pycha; Shahrokh F Shariat
Smoking reduces the efficacy of intravesical bacillus Calmette-Guérin immunotherapy in non-muscle-invasive bladder cancer.
European urology 2012;62(6):1204-6.
2012: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Scott T Tagawa; Derya Tilki; Quoc-Dien Trinh; Bjoern G Volkmer; evanguelos xylinas; Marko Babjuk; Patrick J Bastian; Felix K Chun; Siamak Daneshmand; John P Fitzgerald; Yves Fradet; Hans-Martin Fritsche; David A Green; Jens Hansen; Ashish M Kamat; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Axel S Merseburger; Giacomo Novara; Robert S Svatek
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
World journal of urology 2012;30(6):807-14.
2012: Michael Rink; Douglas S Scherr; Christian Seitz; Daniel Sjoberg; Andrew J Vickers; evanguelos xylinas; Richard Zigeuner; Karim Bensalah; Eugene K Cha; Felix K Chun; Evi Comploj; Jens Hansen; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Richard K Lee; Yair Lotan; Vitaly Margulis; Juan I Martinez-Salamanca; Surena F Matin; Giacomo Novara; Armin Pycha; Jay D Raman; Mesut Remzi; Shahrokh F Shariat
Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.
Annals of surgical oncology 2012;19(13):4337-44.
2012: Thomas F Chromecki; Colin P Dinney; Harun Fajkovic; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Julian Mauermann; Francesco Montorsi; Giacomo Novara; Karl Pummer; Eila Skinner; Christian G Stief; Robert S Svatek; Derya Tilki; Bjoern G Volkmer; Patrick J Bastian; Eugene K Cha; Shahrokh F Shariat
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
World journal of urology 2012;30(6):753-9.
2012: Oliver Patschan; Shahrokh F Shariat; Ulf-Håkan Stenman; Raheela Ashfaq; Daher C Chade; Kristina Hotakainen; Pierre I Karakiewicz; Yair Lotan; Anders Bjartell
Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.
World journal of urology 2012;30(6):785-94.
2012: David A Green; Pierre I Karakiewicz; E Charles Osterberg; Michael Rink; Douglas S Scherr; evanguelos xylinas; Shahrokh F Shariat
Predictive tools for prostate cancer staging, treatment response and outcomes.
Archivos españoles de urología 2012;65(9):787-807.
2012: Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Conditional survival of patients with metastatic renal-cell carcinoma.
The lancet oncology 2012;13(11):e462.
2012: Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Jens Hansen; Pierre I Karakiewicz
Proof of efficacy is not enough: contemporary management of patients with metastatic renal cell carcinoma with targeted therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(31):3901; author reply 3902.
2012: J Schmitges; Q-D Trinh; L Budäus; Markus Graefen; Hans Heinzer; Hartwig Huland; L Jonas; Pierre I Karakiewicz; R Larbig; Thorsten Schlomm; Thomas Steuber
Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(11):1082-8.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Jens Hansen; Pierre I Karakiewicz
Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
The journal of sexual medicine 2012;9(11):2961-9.
2012: David A Green; Naveen Gumpeni; Pierre I Karakiewicz; Michael Rink; Douglas S Scherr; Eugene K Cha; Matthieu Durand; Shahrokh F Shariat
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques.
BJU international 2012;110(10):1463-70.
2012: Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Orchidee Djahangirian; Michael Ehlert; Khurshid R Ghani; Wooju Jeong; Jay Jhaveri; Mani Menon; Monica Morgan; James O Peabody; Paul Perrotte; Craig G Rogers; Pierre I Karakiewicz
Marital status: a gender-independent risk factor for poorer survival after radical cystectomy.
BJU international 2012;110(9):1301-9.
2012: Quoc-Dien Trinh; Piyush K Agarwal; Marco Bianchi; Khurshid R Ghani; Claudio Jeldres; Wooju Jeong; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Leapfrog volume thresholds and perioperative complications after radical prostatectomy.
Cancer 2012;118(20):4991-8.
2012: Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
The case for partial nephrectomy: action is required.
BJU international 2012;110(8):1097-8.
2012: Giovanni Lughezzani; Arieh L Shalhav; Sergey A Shikanov; Leon Sun; Maxine Sun; Alan E Thong; Andrew J Vickers; Gregory P Zagaya; Kevin C Zorn; David M Albala; Lars Budäus; Angel Cronin; Ofer N Gofrit; David I Lee; Pierre I Karakiewicz
Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy.
European urology 2012;62(4):590-6.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Markus Graefen; Jens Hansen; Francesco Montorsi; Paul Perrotte; Jesse Sammon; Shahrokh F Shariat; Pierre I Karakiewicz
Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis.
European urology 2012;62(4):696-703.
2012: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Robert S Svatek; Marko Babjuk; Eugene K Cha; Siamak Daneshmand; Behfar Ehdaie; Harun Fajkovic; Margit Fisch; Hans-Martin Fritsche; David A Green; Jens Hansen; Pierre I Karakiewicz; Wassim Kassouf; Richard K Lee; Yair Lotan; Vitaly Margulis; Giacomo Novara; Armin Pycha; Jay D Raman
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
European urology 2012;62(4):677-84.
2012: Quoc-Dien Trinh; Piyush K Agarwal; Marco Bianchi; Ali Dabaja; Khurshid R Ghani; Wooju Jeong; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Disparities in access to care at high-volume institutions for uro-oncologic procedures.
Cancer 2012;118(18):4421-6.
2012: Shyam Sukumar; Maxine Sun; Marco Bianchi; Felix K Chun; Jack S Elder; Ariella A Friedman; Khurshid R Ghani; Jens Hansen; Wooju Jeong; Pierre I Karakiewicz; Mani Menon; James O Peabody; Praful Ravi; Jesse Sammon; Shahrokh F Shariat; Quoc-Dien Trinh
National trends and disparities in the use of minimally invasive adult pyeloplasty.
The Journal of urology 2012;188(3):913-8.
2012: Alberto Briganti; Tom Budiharto; Cesare Cozzarini; Nadia Di Muzio; Karin Haustermans; Wolfgang Hinkelbein; Steven Joniau; Pierre I Karakiewicz; Francesco Montorsi; Maxine Sun; Bertrand Tombal; Marco Bianchi; Thomas Wiegel; Hein Van Poppel
Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
European urology 2012;62(3):472-87.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
International journal of urology : official journal of the Japanese Urological Association 2012;19(9):836-44; author reply 844-5.
2012: Marco Roscigno; Douglas S Scherr; Christian Seitz; Thomas J Walton; Roberto Bertini; Joaquin Carballido; Eugene K Cha; Thomas F Chromecki; Harun Fajkovic; Vincenzo Ficarra; Luigi Filippo Da Pozzo; Hans-Martin Fritsche; Pierre I Karakiewicz; Kazumasa Matsumoto; Francesco Montorsi; Richard Naspro; Giacomo Novara; Wolfgang Otto; Armin Pycha; Michael Rink; Shahrokh F Shariat
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
BJU international 2012;110(5):674-81.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study.
International journal of radiation oncology, biology, physics 2012;84(1):95-103.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Mani Menon; Francesco Montorsi; Paul Perrotte; Marco Bianchi; Felix K Chun; Roland Dahlem; Margit Fisch; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
BJU international 2012;110(6 Pt B):E183-90.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Lars Budäus; Markus Graefen; Mani Menon; Francesco Montorsi; Paul Perrotte; Georg Salomon; Thorsten Schlomm; Pierre I Karakiewicz
Venous thromboembolism after radical prostatectomy: the effect of surgical caseload.
BJU international 2012;110(6):828-33.
2012: Hans-Martin Fritsche; Amit Gupta; Arndt Hartmann; Pierre I Karakiewicz; Wassim Kassouf; Juan I Martínez Salamanca; Kazumasa Matsumoto; Giacomo Novara; Wolfgang Otto; Christian Seitz; Shiro Baba; Patrick J Bastian; Maximilian Burger; Vincenzo Ficarra; Kanishka Sircar; Stefan Tritschler; Tom Walton; Wolf Ferdinand Wieland; Filiberto Zattoni; Shahrokh F Shariat
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Urologic oncology 2012;30(5):666-72.
2012: Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz; Jesse Sammon; Quoc-Dien Trinh
Adoption of robotic surgery: an analogy from urologic oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(23):2931-2; author reply 2932-3.
2012: Marco Bianchi; Alberto Briganti; Markus Graefen; Claudio Jeldres; Mani Menon; Malek Meskawi; Francesco Montorsi; James O Peabody; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Pierre I Karakiewicz
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2012;6(4):245-50.
2012: Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Alberto Briganti; Khurshid R Ghani; Claudio Jeldres; Mani Menon; Francesco Montorsi; James O Peabody; Paul Perrotte; Craig G Rogers; Pierre I Karakiewicz
The effect of gender on nephrectomy perioperative outcomes: a national survey.
The Canadian journal of urology 2012;19(4):6337-44.
2012: Praful Ravi; Jesse Sammon; Maxine Sun; Pierre I Karakiewicz; Malek Meskawi; Quoc-Dien Trinh
Re: Complications after prostate biopsy: data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2011; 186: 1830-1834.
The Journal of urology 2012;188(2):677-8.
2012: Firas Abdollah; Marco Bianchi; Alberto Briganti; Umberto Capitanio; Andrea Gallina; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Passoni; Patrizio Rigatti; Nazareno Suardi; Maxine Sun; Manuela Tutolo
National Comprehensive Cancer Network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer.
The Journal of urology 2012;188(2):423-8.
2012: Michael Rink; Nathalie Rioux-Leclercq; Brian D Robinson; Douglas S Scherr; Kanishka Sircar; Guru Sonpavde; Maxine Sun; Karim Bensalah; Eugene K Cha; Felix K Chun; Evi Comploj; David A Green; Charles C Guo; Andrea Haitel; Jens Hansen; Wareef Kabbani; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Yair Lotan; Vitaly Margulis; Casey K Ng; Armin Pycha; Jay D Raman; Mesut Remzi; Shahrokh F Shariat
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
The Journal of urology 2012;188(2):398-404.
2012: Jens Hansen; Marco Bianchi; Felix K-H Chun; Markus Graefen; Nawar Hanna; Malek Meskawi; Paul Perrotte; Michael Rink; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.
Urology 2012;80(2):347-53.
2012: Malek Meskawi; Francesco Montorsi; Paul Perrotte; Michael Rink; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Marco Bianchi; Jens Hansen; Salima Ismail; Pierre I Karakiewicz
A review of integrated staging systems for renal cell carcinoma.
European urology 2012;62(2):303-14.
2012: Shahrokh F Shariat; Kanishka Sircar; Christopher G Wood; Richard Zigeuner; Vitaly Margulis; Shuji Mikami; Casey K Ng; Jay D Raman; Mesut Remzi; Michael Rink; Douglas S Scherr; Karim Bensalah; Felix K Chun; Charles C Guo; Andrea Haitel; Jens Hansen; Wareef Kabbani; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Theresa Koppie; Cord Langner
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
European urology 2012;62(2):224-31.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Does partial nephrectomy at an academic institution result in better outcomes?
World journal of urology 2012;30(4):505-10.
2012: Firas Abdollah; Marco Bianchi; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
The Journal of urology 2012;188(1):73-83.
2012: evanguelos xylinas; Karim Bensalah; Pierre I Karakiewicz; Vitaly Margulis; Michael Rink; Shahrokh F Shariat
Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.
European urology 2012;62(1):e25-6.
2012: J Schmitges; M Sun; Q-D Trinh; F Abdollah; M Bianchi; L Budäus; F K Chun; Markus Graefen; H Isbarn; Pierre I Karakiewicz; Thorsten Schlomm; Thomas Steuber
Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(7):624-9.
2012: Maxine Sun; Marco Bianchi; Jens Hansen; Pierre I Karakiewicz
Insights of modern pathology reports originating from prostate biopsy and radical prostatectomy specimens.
European urology 2012;62(1):40-1.
2012: Firas Abdollah; Marco Bianchi; Renzo Colombo; Andrea Gallina; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Passoni; Patrizio Rigatti; Andrea Salonia; Nazareno Suardi; Maxine Sun; Zhe Tian; Manuela Tutolo; Alberto Briganti
Prediction of functional outcomes after nerve-sparing radical prostatectomy: results of conditional survival analyses.
European urology 2012;62(1):42-52.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
International journal of urology : official journal of the Japanese Urological Association 2012;19(7):645-51.
2012: Maxine Sun; Rodolphe Thuret; Zhe Tian; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Treatment management of small renal masses in the 21st century: a paradigm shift.
Annals of surgical oncology 2012;19(7):2380-7.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.
European journal of cancer (Oxford, England : 1990) 2012;48(10):1503-11.
2012: Faysal A Yafi; Filiberto Zattoni; Assaad El-Hakim; Vincenzo Ficarra; Hans-Martin Fritsche; Amit Gupta; Pierre I Karakiewicz; Juan I Martínez Salamanca; Kazumasa Matsumoto; Giacomo Novara; Christian Seitz; Shahrokh F Shariat; Stefan Trischler; Thomas J Walton; Wassim Kassouf
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
BJU international 2012;110(2 Pt 2):E7-13.
2012: Thomas F Chromecki; Harun Fajkovic; Pierre I Karakiewicz; Karl Pummer; Claus G Roehrborn; Douglas S Scherr; Raheela Ashfaq; Eugene K Cha; Maxine Sun; Ashutosh K Tewari; Shahrokh F Shariat
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
BJU international 2012;110(1):63-8.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
BJU international 2012;110(2 Pt 2):E21-7.
2012: Quoc-Dien Trinh; Khurshid R Ghani; Jesse Sammon; Maxine Sun; Pierre I Karakiewicz
Are medicare-based findings applicable to all prostatectomy patients?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(18):2286-7; author reply 2287.
2012: Jan Schmitges; Shahrokh F Shariat; Thomas Steuber; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Sascha A Ahyai; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.
International urology and nephrology 2012;44(3):799-806.
2012: Maxine Sun; Zhe Tian; Hugues Widmer; Kevin Zorn; Firas Abdollah; Marco Bianchi; Markus Graefen; Francesco Montorsi; Paul Perrotte; Daniel Pharand; Jan Schmitges; Shahrokh F Shariat; Pierre I Karakiewicz
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.
BJU international 2012;109(12):1807-12.
2012: Quoc-Dien Trinh; Khurshid R Ghani; Mani Menon; Maxine Sun; Pierre I Karakiewicz
Re: improved prediction of long-term, other cause mortality in men with prostate cancer: T. J. Daskivich, K. Chamie, L. Kwan, J. Labo, A. Dash, S. Greenfield and M. S. Litwin, J Urol 2011; 186: 1868-1873.
The Journal of urology 2012;187(5):1931.
2012: Kevin C Zorn; Marco Bianchi; Ronald Denis; Gagan Gautam; Claudio Jeldres; Pierre I Karakiewicz; Jean-Baptiste Lattouf; Dan Liberman; Jesse Sammon; Jan Schmitges; Maxine Sun; Quoc-Dien Trinh; Hugues Widmer; Assaad El-Hakim
Prospective randomized trial of barbed polyglyconate suture to facilitate vesico-urethral anastomosis during robot-assisted radical prostatectomy: time reduction and cost benefit.
BJU international 2012;109(10):1526-32.
2012: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Open radical prostatectomy in the elderly: a case for concern?
BJU international 2012;109(9):1335-40.
2012: Quoc-Dien Trinh; Khurshid R Ghani; Wooju Jeong; Jay Jhaveri; Pierre I Karakiewicz; James O Peabody; Jesse Sammon; Jan Schmitges; Maxine Sun; Mani Menon
Variations in the quality of care at radical prostatectomy.
Therapeutic advances in urology 2012;4(2):61-75.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Lars Budäus; Christian Eichelberg; Markus Graefen; Jens Hansen; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy.
Urology 2012;79(4):796-803.
2012: Michael Rink; Brian D Robinson; Arthur I Sagalowsky; Douglas S Scherr; Eugene K Cha; Felix K Chun; Margit Fisch; David Green; Jens Hansen; Pierre I Karakiewicz; Yair Lotan; Shahrokh F Shariat
Biomolecular predictors of urothelial cancer behavior and treatment outcomes.
Current urology reports 2012;13(2):122-35.
2012: Marco Bianchi; Alberto Briganti; Khurshid R Ghani; Claudio Jeldres; Mani Menon; Francesco Montorsi; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Discharge patterns after radical cystectomy: contemporary trends in the United States.
The Journal of urology 2012;187(4):1206-9.
2012: Michael Rink; Eugene K Cha; fianceeyi chun; Harun Fajkovic; Amit Gupta; Pierre I Karakiewicz; Yair Lotan; Shahrokh F Shariat
Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma.
European urology 2012;61(4):854-5.
2012: Nawar Hanna; Jens Hansen; Marco Bianchi; Markus Graefen; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series.
European urology 2012;61(4):715-21.
2012: Quoc-Dien Trinh; Marco Bianchi; Khurshid R Ghani; Jens Hansen; Claudio Jeldres; Wooju Jeong; Mani Menon; Francesco Montorsi; James O Peabody; Praful Ravi; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Pierre I Karakiewicz
Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample.
European urology 2012;61(4):679-85.
2012: Maxine Sun; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Nawar Hanna; Jens Hansen; Pierre I Karakiewicz
A non-cancer-related survival benefit is associated with partial nephrectomy.
European urology 2012;61(4):725-31.
2012: Maxine Sun; Jens Hansen; Pierre I Karakiewicz
Re: Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.
European urology 2012;61(4):e37-8.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Morbidity and mortality of radical prostatectomy differs by insurance status.
Cancer 2012;118(7):1803-10.
2012: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States.
Cancer 2012;118(7):1894-900.
2012: Al'a Abdo; Marco Bianchi; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Kevin Zorn; Pierre I Karakiewicz
The effect of insurance status on outcomes after partial nephrectomy.
International urology and nephrology 2012;44(2):343-51.
2012: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
BJU international 2012;109(8):1147-54.
2012: Firas Abdollah; Alberto Briganti; Al'a Abdo; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy.
BJU international 2012;109(8):1177-82.
2012: Jochen Walz; Franck Bladou; Alberto Briganti; Felix K-H Chun; Gwenaelle Gravis; Pierre I Karakiewicz; Julien Laroche; Bertrand Rousseau; Naji Salem; Georges Fournier
Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
Urology 2012;79(3):546-51.
2012: Harun Fajkovic; Vincenzo Ficarra; Claudio Jeldres; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Yair Lotan; Vitaly Margulis; Kazumasa Matsumoto; Francesco Montorsi; Giacomo Novara; Armin Pycha; Jay D Raman; Mesut Remzi; Marco Roscigno; Douglas S Scherr; Christian Seitz; Karim Bensalah; Eckart Breinl; Eugene K Cha; Thomas F Chromecki; Gerhard Donner; Alon Z Weizer; Shahrokh F Shariat
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
The Journal of urology 2012;187(3):845-51.
2012: Alberto Briganti; umberto capitanio; Massimo Freschi; Andrea Gallina; Pierre I Karakiewicz; Alessandro Larcher; Patrizio Rigatti; Andrea Salonia; Nazareno Suardi; Maxine Sun; Firas Abdollah; Marco Bianchi; Francesco Montorsi
Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
European urology 2012;61(3):480-7.
2012: Christopher E Barbieri; Eugene K Cha; Thomas F Chromecki; Allison Dunning; Pierre I Karakiewicz; Yair Lotan; Madhu Mazumdar; Douglas S Scherr; Maxine Sun; Robert S Svatek; Shahrokh F Shariat
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
BJU international 2012;109(5):685-90.
2012: Quoc-Dien Trinh; Jesse Sammon; Maxine Sun; Pierre I Karakiewicz
Venous thromboembolism in colorectal surgery: how much does laparoscopy impart an advantage?
Archives of surgery (Chicago, Ill. : 1960) 2012;147(2):199.
2012: Jan Schmitges; Maxine Sun; Quoc-Dien Trinh; Paul Perrotte; Thorsten Schlomm; Firas Abdollah; Marco Bianchi; Lars Budäus; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Blood transfusions in radical prostatectomy: a contemporary population-based analysis.
Urology 2012;79(2):332-8.
2012: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
BJU international 2012;109(4):564-9.
2012: Viktor Grünwald; Robert Hawkins; Pierre I Karakiewicz; Jennifer J Knox; James Larkin; Se-Hoon Lee; Jean-Pascal Machiels; Kurt Miller; Nicoletta Pirotta; Sun Young Rha; Marianne Rosamilia; Oezlem Anak; Sevil E Bavbek; Christian U Blank; István Bodrogi; Petri Bono; Jocelyn Booth; Daniel Castellano
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.
European journal of cancer (Oxford, England : 1990) 2012;48(3):324-32.
2012: Daniel Taussky; Pierre I Karakiewicz; Mathieu Latour; Normand Blais
Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment.
Rare tumors 2012;4(1):e17.
2012: Philipp Nuhn; Paul Perrotte; Maxine Sun; Derya Tilki; Lutz Trojan; Wolf F Wieland; Christian Bolenz; Sabine Brookman-May; Alexander Buchner; Maximilian Burger; Hans-Martin Fritsche; Axel Haferkamp; Edwin Herrmann; Markus Hohenfellner; Pierre I Karakiewicz; Matthias May; Rudolf Moritz; Stefan C Müller; Patrick J Bastian
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
European urology 2012;61(1):58-64.
2011: Firas Abdollah; Alberto Briganti; Orchidee Djahangirian; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
Urology 2011;78(6):1363-7.
2011: M Rink; B Robinson; D S Scherr; K Bensalah; F K H Chun; M Fisch; Pierre I Karakiewicz; R K Lee; V Margulis; M Sun; Shahrokh F Shariat
Tissue-based molecular markers for renal cell carcinoma.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2011;63(4):293-308.
2011: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Hugues Widmer; Kevin Zorn; Firas Abdollah; Marco Bianchi; Claudio Jeldres; Mani Menon; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
European urology 2011;60(6):1152-9.
2011: Firas Abdollah; Alberto Briganti; Umberto Capitanio; Andrea Gallina; Francesco Montorsi; Paul Perrotte; Patrizio Rigatti; Andrea Salonia; Jan Schmitges; Shahrokh F Shariat; Nazareno Suardi; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy.
BJU international 2011;108(11):1769-75.
2011: Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Editorial comment.
The Journal of urology 2011;186(5):1777-8.
2011: Shahrokh F Shariat; Christopher E Barbieri; Thomas F Chromecki; Zoran Culig; Julia Hoefer; Pierre I Karakiewicz; Francesco Montorsi; Claus G Roehrborn; Douglas S Scherr; Ilaria T Cavarretta
Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.
The Journal of urology 2011;186(5):2107-14.
2011: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.
The Journal of urology 2011;186(5):1849-54.
2011: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrohk F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
European urology 2011;60(5):920-30.
2011: Jay D Raman; Mesut Remzi; Marco Roscigno; Arthur I Sagalowsky; Douglas S Scherr; Shahrokh F Shariat; Matthias Waldert; Alon Z Weizer; Jeffery C Wheat; Christopher G Wood; Christian Bolenz; Pierre I Karakiewicz; Yair Lotan; Vitaly Margulis; Francesco Montorsi; Casey K Ng
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
Urologic oncology 2011;29(6):716-23.
2011: Maxine Sun; Richard Zigeuner; Christopher Cheng; Vincenzo Ficarra; Masaru Murai; Stéphane Oudard; Allan J Pantuck; Shahrokh F Shariat; Pierre I Karakiewicz
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
European urology 2011;60(4):644-61.
2011: Maxine Sun; Zhe Tian; Firas Abdollah; Lars Budaüs; Markus Greafen; Rupinder Johal; Daniel Liberman; Francesco Montorsi; Monica Morgan; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Pierre I Karakiewicz
Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.
Annals of surgical oncology 2011;18(10):2997-3004.
2011: Kazumasa Matsumoto; Francesco Montorsi; Casey Ng; Giacomo Novara; Jay D Raman; Mesut Remzi; Joaquin Carballido Rodriguez; Marco Roscigno; Christian Seitz; Karim Bensalah; Christian Bolenz; Vincenzo Ficarra; Hans-Martin Fritsche; Amit Gupta; Masatsugu Iwamura; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Theresa Koppie; Vitaly Margulis; Guido Martignoni; Stefan Tritschler; Thomas J Walton; Alon Z Weizer; Christopher G Wood; Richard Zigeuner; Shahrokh F Shariat
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU international 2011;108(8 Pt 2):E304-9.
2011: Firas Abdollah; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.
Annals of surgical oncology 2011;18(10):2988-96.
2011: Maxine Sun; Rodolphe Thuret; Zhe Tian; Al'a Abdo; Firas Abdollah; Daniel Liberman; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis.
Cancer 2011;117(18):4277-85.
2011: Firas Abdollah; Orchidee Djahangirian; Markus Graefen; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.
The Journal of urology 2011;186(3):824-8.
2011: Kazuhito Matsushita; Douglas S Scherr; Maxine Sun; Shiro Baba; Eugene K Cha; Thomas F Chromecki; Harun Fajkovic; Pierre I Karakiewicz; Kazumasa Matsumoto; Shahrokh F Shariat
Immunohistochemical biomarkers for bladder cancer prognosis.
International journal of urology : official journal of the Japanese Urological Association 2011;18(9):616-29.
2011: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study.
Annals of surgical oncology 2011;18(9):2680-7.
2011: Lars Budäus; Markus Graefen; Alexander Haese; Hendrik Isbarn; Rupinder Johal; Firas Abdollah; Giovanni Lughezzani; Francesco Montorsi; Monica Morgan; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Kevin C Zorn; Pierre I Karakiewicz
The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study.
BJU international 2011;108(6):888-93.
2011: Guru Sonpavde; Robert S Svatek; Derya Tilki; Eila Skinner; Gilad E Amiel; Patrick J Bastian; Colin P Dinney; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Myrna M Khan; Richard Lee; Seth P Lerner; Yair Lotan; Giacomo Novara; Shahrokh F Shariat
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
BJU international 2011;108(5):687-92.
2011: Rodolphe Thuret; Firas Abdollah; Jacques Guiter; François Iborra; Jean-Jacques Patard; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Pierre I Karakiewicz
Conditional survival predictions after surgery for patients with penile carcinoma.
Cancer 2011;117(16):3723-30.
2011: Thomas F Chromecki; Pierre I Karakiewicz; Giacomo Novara; Mesut Remzi; Douglas S Scherr; Shahrokh F Shariat; Grégory Verhoest; Karim Bensalah; Eugene K Cha
Prognostic factors for upper urinary tract urothelial carcinoma.
Nature reviews. Urology 2011;8(8):440-7.
2011: Harun Fajkovic; Joshua A Halpern; Pierre I Karakiewicz; Axel S Merseburger; Atessa Bahadori; Eckart Breinl; Eugene K Cha; Thomas F Chromecki; Shahrokh F Shariat
Impact of gender on bladder cancer incidence, staging, and prognosis.
World journal of urology 2011;29(4):457-63.
2011: Firas Abdollah; Claudio Jeldres; Al'a Abdo; Francesco Montorsi; Monica Morgan; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study.
Cancer causes & control : CCC 2011;22(8):1085-95.
2011: Thomas F Chromecki; Felix K Chun; Behfar Ehdaie; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Richard K Lee; Juan I Martínez Salamanca; Kazumasa Matsumoto; Casey Ng; Giacomo Novara; Karl Pummer; Armin Pycha; Jay D Raman; Douglas S Scherr; Christian Seitz; Patrick J Bastian; Eugene K Cha; Thomas J Walton; Richard Zigeuner; Shahrokh F Shariat
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
World journal of urology 2011;29(4):473-80.
2011: Wolfgang Otto; Armin Pycha; Christian Seitz; Shahrokh F Shariat; Stefan Tritschler; Thomas J Walton; Shiro Baba; Patrick J Bastian; Maximilian Burger; Vincenzo Ficarra; Hans-Martin Fritsche; Amit Gupta; Pierre I Karakiewicz; Wassim Kassouf; Guido Martignoni; Juan I Martínez Salamanca; Kazumasa Matsumoto; Giacomo Novara
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.
World journal of urology 2011;29(4):487-94.
2011: Thomas J Walton; Stephen A Thomas; Stefan Tritschler; Walter Artibani; Patrick J Bastian; Maximilian Burger; Vincenzo Ficarra; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Juan I Martínez Salamanca; Kazumasa Matsumoto; Giacomo Novara; Christian Seitz; Shahrokh F Shariat
Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
BJU international 2011;108(3):406-12.
2011: Shahrokh F Shariat; Stefan Tritschler; Thomas J Walton; Wolfgang Otto; Armin Pycha; Christian Seitz; Shiro Baba; Patrick J Bastian; Ricardo L Favaretto; Vincenzo Ficarra; Hans-Martin Fritsche; Amit Gupta; Pierre I Karakiewicz; Wassim Kassouf; Juan I Martínez Salamanca; Kazumasa Matsumoto; Kazuhito Matsushita; Giacomo Novara
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.
World journal of urology 2011;29(4):481-6.
2011: Shahrokh F Shariat; Maxine Sun; Thomas F Chromecki; Pierre I Karakiewicz; Richard K Lee; Giovanni Lughezzani; Michael J Marberger; Mesut Remzi; Caroline Savage; Douglas S Scherr; Andrew J Vickers
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.
Cancer 2011;117(13):2892-7.
2011: Behfar Ehdaie; Pierre I Karakiewicz; Richard K Lee; Yair Lotan; William T Lowrance; Vitaly Margulis; Casey Ng; Giacomo Novara; Jay D Raman; Douglas Scherr; Thomas F Chromecki; Shahrokh F Shariat
Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.
The Journal of urology 2011;186(1):66-72.
2011: Pierre I Karakiewicz; Maxine Sun; Joaquin Bellmunt; Vesna Sneller; Bernard Escudier
Prediction of progression-free survival rates after bevacizumab plus interferon versus interferon alone in patients with metastatic renal cell carcinoma: comparison of a nomogram to the Motzer criteria.
European urology 2011;60(1):48-56.
2011: Kevin C Zorn; Naeem Bhojani; Ronald Denis; Pierre I Karakiewicz; Jean-Baptiste Lattouf; Dan Liberman; Maxine Sun; Quoc-Dien Trinh; Hugues Widmer; Assaad El-Hakim
Novel method of knotless vesicourethral anastomosis during robot-assisted radical prostatectomy: feasibility study and early outcomes in 30 patients using the interlocked barbed unidirectional V-LOC180 suture.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2011;5(3):188-94.
2011: Firas Abdollah; Maxine Sun; Shahrokh F Shariat; Jan Schmitges; Orchidee Djahangirian; Zhe Tian; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.
The Journal of urology 2011;185(6):2078-84.
2011: L Budäus; M Morgan; F Abdollah; K C Zorn; M Sun; R Johal; R Thuret; A Abdo; J Schmitges; H Isbarn; Claudio Jeldres; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Impact of annual surgical volume on length of stay in patients undergoing minimally invasive prostatectomy: a population-based study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011;37(5):429-34.
2011: R Thuret; C Maurin; M Sun; Paul Perrotte; Pierre I Karakiewicz
[Treatment of metastatic renal cell carcinoma].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2011;21(4):233-44.
2011: Guru Sonpavde; Myrna M Khan; Robert S Svatek; Richard Lee; Giacomo Novara; Derya Tilki; Seth P Lerner; Gilad E Amiel; Eila Skinner; Pierre I Karakiewicz; Patrick J Bastian; Wassim Kassouf; Hans-Martin Fritsche; Jonathan I Izawa; Douglas S Scherr; Vincenzo Ficarra; Colin P Dinney; Yair Lotan; Yves Fradet; Shahrokh F Shariat
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy.
The Journal of urology 2011;185(4):1216-21.
2011: Mark H Katz; Sergey Shikanov; Maxine Sun; Firas Abdollah; Lars Budaeus; Edward M Gong; Scott E Eggener; Gary D Steinberg; Gregory P Zagaja; Arieh L Shalhav; Pierre I Karakiewicz; Kevin C Zorn
Gleason 6 prostate cancer in one or two biopsy cores can harbor more aggressive disease.
Journal of endourology / Endourological Society 2011;25(4):699-703.
2011: umberto capitanio; Federico Pellucchi; Andrea Gallina; Alberto Briganti; Nazareno Suardi; Andrea Salonia; Firas Abdollah; Ettore Di Trapani; Claudio Jeldres; Andrea Cestari; Pierre I Karakiewicz; Francesco Montorsi
How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications.
BJU international 2011;107(7):1095-101.
2011: Daniel Liberman; Giovanni Lughezzani; Maxine Sun; Ahmed Alasker; Rodolphe Thuret; Firas Abdollah; Lars Budaus; Hugues Widmer; Markus Graefen; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
Urology 2011;77(3):660-6.
2011: Robert S Svatek; Shahrokh F Shariat; Giacomo Novara; Eila C Skinner; Yves Fradet; Patrick J Bastian; Ashish M Kamat; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Vincenzo Ficarra; Bjoern G Volkmer; Hendrik Isbarn; Colin P Dinney
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort.
BJU international 2011;107(6):898-904.
2011: Firas Abdollah; Lars Budäus; Maxine Sun; Monica Morgan; Rupinder Johal; Rodolphe Thuret; Kevin C Zorn; Hendrik Isbarn; Alexander Haese; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Impact of caseload on total hospital charges: a direct comparison between minimally invasive and open radical prostatectomy--a population based study.
The Journal of urology 2011;185(3):855-61.
2011: Lars Budäus; Maxine Sun; Firas Abdollah; Kevin C Zorn; Monica Morgan; Rupinder Johal; Daniel Liberman; Rodolphe Thuret; Hendrik Isbarn; Georg Salomon; Alexander Haese; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based study.
Annals of surgical oncology 2011;18(3):839-47.
2011: Jochen Walz; Steven Joniau; fianceeyi chun; Hendrik Isbarn; Claudio Jeldres; Ofer Yossepowitch; Hsu Chao-Yu; Eric A Klein; Peter T Scardino; Alwyn M Reuther; Hein Van Poppel; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.
BJU international 2011;107(5):765-70.
2011: Daniel Liberman; Ahmed Alasker; Maxine Sun; Salima Ismail; Giovanni Lughezzani; Claudio Jeldres; Lars Budaus; Rodolphe Thuret; Shahrokh F Shariat; Hugues Widmer; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
BJU international 2011;107(6):905-11.
2011: Guru Sonpavde; Myrna M Khan; Seth P Lerner; Robert S Svatek; Giacomo Novara; Pierre I Karakiewicz; Eila Skinner; Derya Tilki; Wassim Kassouf; Yves Fradet; Colin P Dinney; Hans-Martin Fritsche; Jonathan I Izawa; Patrick J Bastian; Vincenzo Ficarra; Mark P Schoenberg; Arthur I Sagalowsky; Yair Lotan; Shahrokh F Shariat
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.
The Journal of urology 2011;185(2):456-61.
2011: Rodolphe Thuret; Maxine Sun; Firas Abdollah; Lars Budaus; Giovanni Lughezzani; Daniel Liberman; Monica Morgan; Rupinder Johal; Claudio Jeldres; Mathieu Latour; Shahrokh F Shariat; François Iborra; Jacques Guiter; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.
The Journal of urology 2011;185(2):501-7.
2011: Rodolphe Thuret; Maxine Sun; Giovanni Lughezzani; Lars Budaus; Daniel Liberman; Firas Abdollah; Monica Morgan; Rupinder Johal; Claudio Jeldres; Mathieu Latour; Shahrokh F Shariat; François Iborra; Jacques Guiter; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.
Annals of surgical oncology 2011;18(2):439-46.
2011: Philipp Nuhn; Eila Skinner; Guru Sonpavde; Robert S Svatek; Derya Tilki; Patrick J Bastian; Colin P Dinney; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Hendrik Isbarn; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Francesco Montorsi; Stefan C Müller; Giacomo Novara; Shahrokh F Shariat
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
Urologia internationalis 2011;87(1):42-8.
2011: Maxine Sun; Rodolphe Thuret; Firas Abdollah; Giovanni Lughezzani; Jan Schmitges; Zhe Tian; Shahrokh F Shariat; Francesco Montorsi; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.
European urology 2011;59(1):135-41.
2011: Firas Abdollah; Maxine Sun; Rodolphe Thuret; Claudio Jeldres; Zhe Tian; Alberto Briganti; Shahrokh F Shariat; Paul Perrotte; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.
European urology 2011;59(1):88-95.
2011: Giovanni Lughezzani; Maxine Sun; Shahrokh F Shariat; Lars Budäus; Rodolphe Thuret; Claudio Jeldres; Daniel Liberman; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer.
Cancer 2011;117(1):103-9.
2010: Firas Abdollah; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Should all men having a radical prostatectomy have a pelvic lymph node dissection? No.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2010;4(6):425-6.
2010: Maxine Sun; Al'a Abdo; Firas Abdollah; Jan Schmitges; Rodolphe Thuret; Claudio Jeldres; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Management of upper urinary tract urothelial carcinoma.
Expert review of anticancer therapy 2010;10(12):1955-65.
2010: Lars Budäus; Firas Abdollah; Maxine Sun; Monica Morgan; Rupinder Johal; Rodolphe Thuret; Kevin C Zorn; Hendrik Isbarn; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends.
The Journal of urology 2010;184(6):2285-90.
2010: Firas Abdollah; Maxine Sun; Rodolphe Thuret; Lars Budäus; Claudio Jeldres; Markus Graefen; Alberto Briganti; Paul Perrotte; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
European urology 2010;58(6):882-92.
2010: Kevin C Zorn; Naeem Bhojani; Gagan Gautam; Sergey Shikanov; Ofer N Gofrit; Gautam Jayram; Mark H Katz; Ilias Cagiannos; Lars Budaus; Firas Abdollah; Maxine Sun; Pierre I Karakiewicz; Arieh L Shalhav; Hikmat Al-Ahmadie
Application of ice cold irrigation during vascular pedicle control of robot-assisted radical prostatectomy: EnSeal instrument cooling to reduce collateral thermal tissue damage.
Journal of endourology / Endourological Society 2010;24(12):1991-6.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Ahmed Alasker; Claudio Jeldres; Hendrik Isbarn; Lars Budäus; Jean-Baptiste Lattouf; Luc Valiquette; François Bénard; Fred Saad; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy.
International journal of radiation oncology, biology, physics 2010;78(5):1307-13.
2010: Christian Seitz; Amit Gupta; Shahrokh F Shariat; Kazumasa Matsumoto; Wassim Kassouf; Thomas J Walton; Hans-Martin Fritsche; Wolfgang Otto; Stefan Tritschler; Patrick J Bastian; Joaquin Carballido; Vincenzo Ficarra; Pierre I Karakiewicz; Walter Artibani; Guido Mazzoleni; Giacomo Novara
Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.
The Journal of urology 2010;184(5):1895-900.
2010: Giovanni Lughezzani; Alberto Briganti; Pierre I Karakiewicz; Michael W Kattan; Francesco Montorsi; Shahrokh F Shariat; Andrew J Vickers
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.
European urology 2010;58(5):687-700.
2010: Maxime Crépel; Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Ahmed Alasker; umberto capitanio; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Urology 2010;76(4):883-8.
2010: Lars Budäus; Markus Graefen; Georg Salomon; Hendrik Isbarn; Giovanni Lughezzani; Maxine Sun; Felix K H Chun; Thorsten Schlomm; Thomas Steuber; Alexander Haese; Jens Koellermann; Guido Sauter; Margit Fisch; Hans Heinzer; Hartwig Huland; Pierre I Karakiewicz
The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.
International journal of urology : official journal of the Japanese Urological Association 2010;17(10):862-8.
2010: Lars Budäus; Hendrik Isbarn; Christian Eichelberg; Giovanni Lughezzani; Maxine Sun; Paul Perrotte; fianceeyi chun; Georg Salomon; Thomas Steuber; Jens Köllermann; Guido Sauter; Sascha A Ahyai; Mario Zacharias; Margit Fisch; Thorsten Schlomm; Alexander Haese; Hans Heinzer; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
The Journal of urology 2010;184(4):1341-6.
2010: Christian Bolenz; Shahrokh F Shariat; Pierre I Karakiewicz; Raheela Ashfaq; Richard Ho; Arthur I Sagalowsky; Yair Lotan
Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder.
BJU international 2010;106(8):1216-22.
2010: C E Barbieri; Y Lotan; R K Lee; Guru Sonpavde; Pierre I Karakiewicz; B Robinson; Douglas Scherr; Shahrokh F Shariat
Tissue-based molecular markers for bladder cancer.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2010;62(3):241-58.
2010: Robert S Svatek; Shahrokh F Shariat; Robert E Lasky; Eila C Skinner; Giacomo Novara; Seth P Lerner; Yves Fradet; Patrick J Bastian; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Stefan C Müller; Jonathan I Izawa; Vincenzo Ficarra; Arthur I Sagalowsky; Mark P Schoenberg; Arlene Siefker-Radtke; Randall E Millikan; Colin P N Dinney
The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(17):4461-7.
2010: Derya Tilki; Robert S Svatek; Giacomo Novara; Michael Seitz; Guilherme Godoy; Pierre I Karakiewicz; Wassim Kassouf; Yves Fradet; Hans-Martin Fritsche; Guru Sonpavde; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Mark P Schoenberg; Christian G Stief; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Oliver Reich; Shahrokh F Shariat
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
The Journal of urology 2010;184(3):888-94.
2010: Umberto Capitanio; Alberto Briganti; Andrea Gallina; Nazareno Suardi; Pierre I Karakiewicz; Francesco Montorsi; Vincenzo Scattoni
Predictive models before and after radical prostatectomy.
The Prostate 2010;70(12):1371-8.
2010: Maxine Sun; Shahrokh F Shariat; Pierre I Karakiewicz
Factors affecting outcome in renal cell carcinoma.
Current opinion in urology 2010;20(5):355-60.
2010: Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Shahrokh F Shariat; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
Cancer 2010;116(16):3774-84.
2010: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Giacomo Novara; Michael Seitz; Guru Sonpavde; Amit Gupta; Wassim Kassouf; Yves Fradet; Vincenzo Ficarra; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Christian G Stief; Oliver Reich; Shahrokh F Shariat
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
The Journal of urology 2010;184(2):470-4.
2010: Vitaly Margulis; Ramy F Youssef; Pierre I Karakiewicz; Yair Lotan; Christopher G Wood; Richard Zigeuner; Eiji Kikuchi; Alon Z Weizer; Jay D Raman; Mesut Remzi; Marco Roscigno; Francesco Montorsi; Christian Bolenz; Wassim Kassouf; Shahrokh F Shariat
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
The Journal of urology 2010;184(2):453-8.
2010: Sascha A Ahyai; Mario Zacharias; Hendrik Isbarn; Thomas Steuber; Christian Eichelberg; Jens Köllermann; Margit Fisch; Pierre I Karakiewicz; Hartwig Huland; Markus Graefen; fianceeyi chun
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.
BJU international 2010;106(4):478-83.
2010: Shahrokh F Shariat; Yair Lotan; Andrew J Vickers; Pierre I Karakiewicz; Bernd J Schmitz-Dräger; Peter J Goebell; Núria Malats
Statistical consideration for clinical biomarker research in bladder cancer.
Urologic oncology 2010;28(4):389-400.
2010: Giovanni Lughezzani; Pierre I Karakiewicz; Pierre Bigot; Paul Perrotte; Maxime Crépel; Nathalie Rioux-Leclercq; Véronique Catros-Quemener; Jacques-Philippe Moulinoux; Françoise Bouet; Bernard Cipolla; Jean-Jacques Patard
The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2010;46(10):1927-35.
2010: Derya Tilki; Oliver Reich; Pierre I Karakiewicz; Giacomo Novara; Wassim Kassouf; Süleyman Ergün; Yves Fradet; Vincenzo Ficarra; Guru Sonpavde; Christian G Stief; Eila Skinner; Robert S Svatek; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.
European urology 2010;58(1):112-7.
2010: Hendrik Isbarn; Pierre I Karakiewicz; Susanne Vogel; Claudio Jeldres; Giovanni Lughezzani; Alberto Briganti; Francesco Montorsi; Paul Perrotte; Sascha A Ahyai; Lars Budäus; Christian Eichelberg; Roman Heuer; Jens Köllermann; Guido Sauter; Thorsten Schlomm; Thomas Steuber; Alexander Haese; Mario Zacharias; Margit Fisch; Hans Heinzer; Hartwig Huland; fianceeyi chun; Markus Graefen
Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
International journal of radiation oncology, biology, physics 2010;77(3):784-7.
2010: Hendrik Isbarn; Pierre I Karakiewicz; Jochen Walz; Sascha A Ahyai; Thomas Steuber; Alexander Haese; Lars Budäus; Thorsten Schlomm; Christian Eichelberg; Roman Heuer; Hans Heinzer; Hartwig Huland; Markus Graefen; fianceeyi chun
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.
International journal of radiation oncology, biology, physics 2010;77(3):788-92.
2010: Giovanni Lughezzani; Maxine Sun; Lars Budäus; Rodolphe Thuret; Paul Perrotte; Pierre I Karakiewicz
Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(18):e299-300; author reply e301.
2010: Claudio Jeldres; Maxine Sun; Paul Perrotte; Pierre I Karakiewicz
Pazopanib trial data cannot support first-line use.
Nature reviews. Urology 2010;7(6):307-8.
2010: Pierre I Karakiewicz; Maxine Sun
Editorial comment.
Urology 2010;75(6):1404; author reply 1404-5.
2010: Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Pierre I Karakiewicz
Treatment of metastatic renal cell carcinoma.
Nature reviews. Urology 2010;7(6):327-38.
2010: Giacomo Novara; Robert S Svatek; Pierre I Karakiewicz; Eila Skinner; Vincenzo Ficarra; Yves Fradet; Yair Lotan; Hendrik Isbarn; Umberto Capitanio; Patrick J Bastian; Wassim Kassouf; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Colin P Dinney; Seth P Lerner; Mark P Schoenberg; Bjoern G Volkmer; Arthur I Sagalowsky; Shahrokh F Shariat
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.
The Journal of urology 2010;183(6):2165-70.
2010: Giacomo Novara; Kazumasa Matsumoto; Wassim Kassouf; Thomas J Walton; Hans-Martin Fritsche; Patrick J Bastian; Juan I Martínez Salamanca; Christian Seitz; R John Lemberger; Maximilian Burger; Assaad El-Hakim; Shiro Baba; Guido Martignoni; Amit Gupta; Pierre I Karakiewicz; Vincenzo Ficarra; Shahrokh F Shariat
Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.
European urology 2010;57(6):1064-71.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Lars Budaus; Ahmed Alasker; AJ Duclos; Hugues Widmer; Mathieu Latour; Giorgio Guazzoni; Francesco Montorsi; Pierre I Karakiewicz
Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study.
European urology 2010;57(6):956-62.
2010: Nazareno Suardi; Alberto Briganti; Andrea Gallina; Andrea Salonia; Pierre I Karakiewicz; umberto capitanio; Massimo Freschi; Andrea Cestari; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi
Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer.
BJU international 2010;105(11):1548-52.
2010: Shahrokh F Shariat; Guilherme Godoy; Yair Lotan; Michael Droller; Pierre I Karakiewicz; Jay D Raman; Hendrik Isbarn; Alon Z Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Christian Bolenz; Karim Bensalah; Theresa Koppie; Wassim Kassouf; Jeffrey C Wheat; Richard Zigeuner; Cord Langner; Christopher G Wood; Vitaly Margulis
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy.
BJU international 2010;105(12):1672-7.
2010: Hendrik Isbarn; Jean-Jacques Patard; Giovanni Lughezzani; Nathalie Rioux-Leclercq; Maxime Crépel; Luca Cindolo; Alexandre de la Taille; Laurent Zini; Arnauld Villers; Shahrokh F Shariat; Roberto Bertini; Pierre I Karakiewicz
Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Urology 2010;75(6):1378-84.
2010: Shahrokh F Shariat; Daher C Chade; Pierre I Karakiewicz; Douglas S Scherr; Guido Dalbagni
Update on intravesical agents for non-muscle-invasive bladder cancer.
Immunotherapy 2010;2(3):381-92.
2010: Derya Tilki; Oliver Reich; Robert S Svatek; Pierre I Karakiewicz; Wassim Kassouf; Giacomo Novara; Vincenzo Ficarra; Daher C Chade; Hans-Martin Fritsche; Niklas Gerwens; Jonathan I Izawa; Seth P Lerner; Mark P Schoenberg; Christian G Stief; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
The Journal of urology 2010;183(5):1757-63.
2010: Shahrokh F Shariat; Ramy F Youssef; Amit Gupta; Daher C Chade; Pierre I Karakiewicz; Hendrik Isbarn; Claudio Jeldres; Arthur I Sagalowsky; Raheela Ashfaq; Yair Lotan
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.
The Journal of urology 2010;183(5):1744-50.
2010: Shahrokh F Shariat; Robert S Svatek; Derya Tilki; Eila Skinner; Pierre I Karakiewicz; Umberto Capitanio; Patrick J Bastian; Bjoern G Volkmer; Wassim Kassouf; Giacomo Novara; Hans-Martin Fritsche; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish M Kamat; Colin P Dinney; Yair Lotan; Michael J Marberger; Yves Fradet
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
BJU international 2010;105(10):1402-12.
2010: Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; Shahrokh F Shariat; Lars Budaus; Jean-Baptiste Lattouf; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
The Journal of urology 2010;183(4):1324-9.
2010: Giovanni Lughezzani; Lars Budäus; Hendrik Isbarn; Maxine Sun; Paul Perrotte; Alexander Haese; fianceeyi chun; Thorsten Schlomm; Thomas Steuber; Hans Heinzer; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
European urology 2010;57(4):562-8.
2010: Richard Zigeuner; Shahrokh F Shariat; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Alon Z Weizer; Eiji Kikuchi; Mesut Remzi; Jay D Raman; Christian Bolenz; Karim Bensalah; umberto capitanio; Theresa Koppie; Wassim Kassouf; Kanishka Sircar; Jean-Jacques Patard; Mario I Fernández; Christopher G Wood; Francesco Montorsi; Philipp Ströbel; Jeffery C Wheat; Andrea Haitel; Mototsugu Oya; Charles C Guo; Casey Ng; Daher C Chade; Arthur Sagalowsky; Cord Langner
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
European urology 2010;57(4):575-81.
2010: Giovanni Lughezzani; Maxine Sun; Lars Budäus; Rodolphe Thuret; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Effect of the number of biopsy cores on prostate cancer detection and staging.
Future oncology (London, England) 2010;6(3):381-90.
2010: Sascha A Ahyai; Hendrik Isbarn; Pierre I Karakiewicz; fianceeyi chun; Mathias Reichert; Jochen Walz; Thomas Steuber; Claudio Jeldres; Thorsten Schlomm; Hans Heinzer; Georg Salomon; Lars Budäus; Paul Perrotte; Hartwig Huland; Markus Graefen; Alexander Haese
The presence of prostate cancer on saturation biopsy can be accurately predicted.
BJU international 2010;105(5):636-41.
2010: Maxine Sun; Giovanni Lughezzani; Ahmed Alasker; Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Lars Budäus; Jean-Baptiste Lattouf; Luc Valiquette; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.
The Journal of urology 2010;183(3):970-5.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Claudio Jeldres; Ahmed Alasker; Hendrik Isbarn; Lars Budäus; Shahrokh F Shariat; Giorgio Guazzoni; Francesco Montorsi; Pierre I Karakiewicz
The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation.
European journal of cancer (Oxford, England : 1990) 2010;46(4):713-9.
2010: Hendrik Isbarn; Pierre I Karakiewicz; Sascha A Ahyai; fianceeyi chun; Claudio Jeldres; Alexander Haese; Hans Heinzer; Mario Zacharias; Roman Heuer; Christian Eichelberg; Thomas Steuber; Lars Budäus; Jens Köllermann; Georg Salomon; Thorsten Schlomm; Paul Perrotte; Margit Fisch; Hartwig Huland; Markus Graefen
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
BJU international 2010;105(6):818-23.
2010: Matthias Waldert; Pierre I Karakiewicz; Jay D Raman; Mesut Remzi; Hendrik Isbarn; Yair Lotan; umberto capitanio; Karim Bensalah; Michael J Marberger; Shahrokh F Shariat
A delay in radical nephroureterectomy can lead to upstaging.
BJU international 2010;105(6):812-7.
2010: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; Markus Graefen; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
BJU international 2010;105(6):799-804.
2010: Naeem Bhojani; umberto capitanio; Nazareno Suardi; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Markus Graefen; Philippe Arjane; AJ Duclos; Jean-Baptiste Lattouf; Fred Saad; Luc Valiquette; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
International journal of radiation oncology, biology, physics 2010;76(2):342-8.
2010: Sara Baillargeon-Gagné; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; umberto capitanio; Shahrokh F Shariat; Maxime Crépel; Ahmed Alasker; Hugues Widmer; Philippe Arjane; Jean-Jacques Patard; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
BJU international 2010;105(3):359-64.
2010: Giovanni Lughezzani; Maxine Sun; Claudio Jeldres; Ahmed Alasker; Lars Budäus; Shahrokh F Shariat; Mathieu Latour; Hugues Widmer; AJ Duclos; Martine Jolivet-Tremblay; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
Urology 2010;75(2):376-81.
2010: Pierre Bigot; Giovanni Lughezzani; Pierre I Karakiewicz; Paul Perrotte; Nathalie Rioux-Leclercq; Véronique Catros-Quemener; Françoise Bouet; Jacques-Philippe Moulinoux; Bernard Cipolla; Jean-Jacques Patard
The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
The Journal of urology 2010;183(2):486-91.
2010: Claudio Jeldres; Maxine Sun; Hendrik Isbarn; Giovanni Lughezzani; Lars Budäus; Ahmed Alasker; Shahrohk F Shariat; Jean-Baptiste Lattouf; Hugues Widmer; Daniel Pharand; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.
Urology 2010;75(2):315-20.
2010: Maxime Crépel; Claudio Jeldres; Paul Perrotte; umberto capitanio; Hendrik Isbarn; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Urology 2010;75(2):271-5.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Lars Budäus; Mathieu Latour; Hugues Widmer; AJ Duclos; Francois Bénard; Michael McCormack; Francesco Montorsi; Pierre I Karakiewicz
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
Urology 2010;75(2):321-7.
2010: Shahrokh F Shariat; John P Sfakianos; Michael J Droller; Pierre I Karakiewicz; Siegfried Meryn; Bernard H Bochner
The effect of age and gender on bladder cancer: a critical review of the literature.
BJU international 2010;105(3):300-8.
2010: Hans-Martin Fritsche; Maximilian Burger; Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Giacomo Novara; Eila Skinner; Stefan Denzinger; Yves Fradet; Hendrik Isbarn; Patrick J Bastian; Bjoern G Volkmer; Francesco Montorsi; Wassim Kassouf; Derya Tilki; Wolfgang Otto; Umberto Capitanio; Jonathan I Izawa; Vincenzo Ficarra; Seth Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish Kamat; Colin P Dinney; Yair Lotan; Shahrokh F Shariat
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
European urology 2010;57(2):300-9.
2010: Shahrokh F Shariat; Christian Bolenz; Pierre I Karakiewicz; Yves Fradet; Raheela Ashfaq; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Jérôme Rigaud; Stefan C Müller; Seth P Lerner; Francesco Montorsi; Arthur I Sagalowsky; Richard J Cote; Yair Lotan
p53 expression in patients with advanced urothelial cancer of the urinary bladder.
BJU international 2010;105(4):489-95.
2010: Christopher R Porter; Nazareno Suardi; Umberto Capitanio; Georg C Hutterer; Koichi Kodama; Robert P Gibbons; Roy Correa; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
A nomogram predicting prostate cancer-specific mortality after radical prostatectomy.
Urologia internationalis 2010;84(2):132-40.
2010: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Hendrik Isbarn; Oliver Reich; Wassim Kassouf; Yves Fradet; Giacomo Novara; Hans-Martin Fritsche; Patrick J Bastian; Jonathan I Izawa; Christian G Stief; Vincenzo Ficarra; Seth P Lerner; Mark P Schoenberg; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.
The Journal of urology 2010;183(1):87-93.
2010: Shahrokh F Shariat; Daher C Chade; Pierre I Karakiewicz; Raheela Ashfaq; Hendrik Isbarn; Yves Fradet; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Francesco Montorsi; Seth P Lerner; Arthur I Sagalowsky; Richard J Cote; Yair Lotan
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.
The Journal of urology 2010;183(1):68-75.
2010: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Maxine Sun; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
Urology 2010;75(1):118-24.
2009: Giovanni Lughezzani; umberto capitanio; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
Cancer 2009;115(24):5680-7.
2009: Catherine Guevremont; Florin I Mija; Hendrik Isbarn; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Pascale Audet; Paul Perrotte; Pierre I Karakiewicz
Dose escalation of second-line sunitinib results in rapid partial remission of multiple hepatic metastases.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(6):E92-3.
2009: Shahrokh F Shariat; Michael W Kattan; Andrew J Vickers; Pierre I Karakiewicz; Peter T Scardino
Critical review of prostate cancer predictive tools.
Future oncology (London, England) 2009;5(10):1555-84.
2009: Claudio Jeldres; Maxine Sun; Daniel Liberman; Giovanni Lughezzani; Alexandre de la Taille; Jacques Tostain; Antoine Valeri; Luca Cindolo; Vincenzo Ficarra; Walter Artibani; Richard Zigeuner; Arnaud Mejean; Jean Luc Descotes; Eric Lechevallier; Peter F Mulders; Paul Perrotte; Jean-Jacques Patard; Pierre I Karakiewicz
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
The Journal of urology 2009;182(6):2585-9.
2009: Pierre I Karakiewicz; Nazareno Suardi; umberto capitanio; Hendrik Isbarn; Claudio Jeldres; Paul Perrotte; Maxine Sun; Vincenzo Ficarra; Richard Zigeuner; Jacques Tostain; Arnaud Mejean; Luca Cindolo; Allan J Pantuck; Arie S Belldegrun; Laurent Zini; Alexandre de la Taille; Denis Chautard; Jean-Luc Descotes; Shahrokh F Shariat; Antoine Valeri; Peter F A Mulders; Hervé Lang; Eric Lechevallier; Jean-Jacques Patard
Conditional survival predictions after nephrectomy for renal cell carcinoma.
The Journal of urology 2009;182(6):2607-12.
2009: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Ahmed Alasker; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
European journal of cancer (Oxford, England : 1990) 2009;45(18):3291-7.
2009: Laurent Zini; umberto capitanio; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Shahrokh F Shariat; Hendrik Isbarn; Philippe Arjane; Hugues Widmer; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma.
BJU international 2009;104(11):1661-7.
2009: Vincent Cloutier; umberto capitanio; Laurent Zini; Paul Perrotte; Claudio Jeldres; Shahrokh F Shariat; Philippe Arjane; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
Thirty-day mortality after nephrectomy: clinical implications for informed consent.
European urology 2009;56(6):998-1003.
2009: Shahrokh F Shariat; Pierre I Karakiewicz; Guilherme Godoy; Jose A Karam; Raheela Ashfaq; Yves Fradet; Hendrik Isbarn; Francesco Montorsi; Claudio Jeldres; Patrick J Bastian; Matthew Nielsen; Stefan C Müller; Arthur I Sagalowsky; Yair Lotan
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7012-9.
2009: Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Hugues Widmer; Philippe Arjane; Daniel Pharand; Margit Fisch; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
The Journal of urology 2009;182(5):2177-81.
2009: Maxine Sun; Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Daniel Pharand; Mathieu Latour; Paul Perrotte; Jean-Jacques Patard; Pierre I Karakiewicz
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
European urology 2009;56(5):775-81.
2009: Claudio Jeldres; Héloise Cardinal; AJ Duclos; Shahrokh F Shariat; Nazareno Suardi; umberto capitanio; Marie-Josèe Hébert; Pierre I Karakiewicz
Prediction of delayed graft function after renal transplantation.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(5):377-82.
2009: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Hugues Widmer; Philippe Arjane; Francois Peloquin; Daniel Pharand; Jean-Jacques Patard; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
The Journal of urology 2009;182(4):1287-93.
2009: Maxime Crépel; Hendrik Isbarn; umberto capitanio; Daniel Liberman; Claudio Jeldres; Maxine Sun; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
Urology 2009;74(4):842-5.
2009: Umberto Capitanio; Hendrik Isbarn; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
Urology 2009;74(4):858-64.
2009: Claudio Jeldres; Sara Baillargeon-Gagne; Daniel Liberman; Hendrik Isbarn; umberto capitanio; Shahrokh F Shariat; Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
Urology 2009;74(4):837-41.
2009: David A Lifshitz; Sergey Shikanov; Claudio Jeldres; Tom Deklaj; Pierre I Karakiewicz; Kevin C Zorn; Scott E Eggener; Arieh L Shalhav
Laparoscopic partial nephrectomy: predictors of prolonged warm ischemia.
The Journal of urology 2009;182(3):860-5.
2009: Shahrokh F Shariat; Yair Lotan; Pierre I Karakiewicz; Raheela Ashfaq; Hendrik Isbarn; Yves Fradet; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Francesco Montorsi; Stefan C Müller; Jose A Karam; Lukas Heukamp; GEORGES NETTO; Seth P Lerner; Arthur I Sagalowsky; Richard J Cote
p53 predictive value for pT1-2 N0 disease at radical cystectomy.
The Journal of urology 2009;182(3):907-13.
2009: Nicholas J Hellenthal; Shahrokh F Shariat; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Christian Bolenz; Mesut Remzi; Alon Z Weizer; Richard Zigeuner; Karim Bensalah; Casey K Ng; Jay D Raman; Eiji Kikuchi; Francesco Montorsi; Mototsugu Oya; Christopher G Wood; Mario Fernandez; Christopher P Evans; Theresa Koppie
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
The Journal of urology 2009;182(3):900-6.
2009: Catherine Guevremont; Ahmed Alasker; Pierre I Karakiewicz
Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma.
Current opinion in supportive and palliative care 2009;3(3):170-9.
2009: umberto capitanio; Paul Perrotte; Laurent Zini; Claudio Jeldres; Shahrokh F Shariat; Hendrik Isbarn; Philippe Arjane; François Peloquin; Daniel Pharand; Francesco Montorsi; Pierre I Karakiewicz
Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
BJU international 2009;104(6):795-9.
2009: Luc Massicotte; Umberto Capitanio; Danielle Beaulieu; Jean-Denis Roy; André Roy; Pierre I Karakiewicz
Independent validation of a model predicting the need for packed red blood cell transfusion at liver transplantation.
Transplantation 2009;88(3):386-91.
2009: Alberto Briganti; Pierre I Karakiewicz; Felix K-H Chun; Nazareno Suardi; Andrea Gallina; Firas Abdollah; Massimo Freschi; Claudio Doglioni; Patrizio Rigatti; Francesco Montorsi
Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
International journal of urology : official journal of the Japanese Urological Association 2009;16(8):676-81.
2009: Hendrik Isbarn; Claudio Jeldres; umberto capitanio; Laurent Zini; Shahrokh F Shariat; Giovanni Lughezzani; Maxine Sun; Sascha A Ahyai; AJ Duclos; Martine Jolivet-Tremblay; Jean-Baptiste Lattouf; Luc Valiquette; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.
Journal of endourology / Endourological Society 2009;23(8):1347-52.
2009: Claudio Jeldres; Hendrik Isbarn; umberto capitanio; Laurent Zini; Naeem Bhojani; Shahrokh F Shariat; Vincent Cloutier; Jean-Baptiste Lattouf; AJ Duclos; Martine Jolivet-Tremblay; Luc Valiquette; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
The Journal of urology 2009;182(2):626-32.
2009: Hendrik Isbarn; Pierre I Karakiewicz; Shahrokh F Shariat; umberto capitanio; Ganesh S Palapattu; Arthur I Sagalowsky; Yair Lotan; Mark P Schoenberg; Gilad E Amiel; Seth P Lerner; Guru Sonpavde
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
The Journal of urology 2009;182(2):459-65; discussion 465.
2009: umberto capitanio; Claudio Jeldres; Paul Perrotte; Hendrik Isbarn; Maxime Crépel; Vincent Cloutier; Sara Baillargeon-Gagne; Shahrokh F Shariat; AJ Duclos; Philippe Arjane; Hugues Widmer; Fred Saad; Francesco Montorsi; Pierre I Karakiewicz
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.
Urology 2009;74(2):373-7.
2009: Hendrik Isbarn; Pierre I Karakiewicz
Risk factors: improved risk stratification for prostate cancer.
Nature reviews. Urology 2009;6(7):355-6.
2009: Alberto Briganti; umberto capitanio; Felix K-H Chun; Pierre I Karakiewicz; Andrea Salonia; Marco Bianchi; Andrea Cestari; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi
Prediction of sexual function after radical prostatectomy.
Cancer 2009;115(13 Suppl):3150-9.
2009: Hendrik Isbarn; Claudio Jeldres; Laurent Zini; Paul Perrotte; Sara Baillargeon-Gagne; umberto capitanio; Shahrokh F Shariat; Phillipe Arjane; Fred Saad; Michael McCormack; Luc Valiquette; Francois Peloquin; AJ Duclos; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A population based assessment of perioperative mortality after cystectomy for bladder cancer.
The Journal of urology 2009;182(1):70-7.
2009: Shahrokh F Shariat; Christian Bolenz; Guilherme Godoy; Yves Fradet; Raheela Ashfaq; Pierre I Karakiewicz; Hendrik Isbarn; Claudio Jeldres; Jérôme Rigaud; Arthur I Sagalowsky; Yair Lotan
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
The Journal of urology 2009;182(1):78-84; discussion 84.
2009: umberto capitanio; Shahrokh F Shariat; Hendrik Isbarn; Alon Z Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Jay D Raman; Christian Bolenz; Karim Bensalah; Theresa Koppie; Wassim Kassouf; Mario I Fernández; Philipp Ströbel; Jeffrey Wheat; Richard Zigeuner; Cord Langner; Matthias Waldert; Mototsugu Oya; Charles C Guo; Casey Ng; Francesco Montorsi; Christopher G Wood; Vitaly Margulis; Pierre I Karakiewicz
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
European urology 2009;56(1):1-9.
2009: Pierre I Karakiewicz; umberto capitanio; Shahrokh Shariat
Editorial comment on: Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries.
European urology 2009;56(1):149-50.
2009: Claudio Jeldres; Karim Bensalah; Umberto Capitanio; Laurent Zini; Paul Perrotte; Nazareno Suardi; Jacques Tostain; Antoine Valeri; Jean-Luc Descotes; Jean-Jacques Rambeaud; Alexandre de la Taille; Laurent Salomon; Claude Abbou; Jean-Jacques Patard; Pierre I Karakiewicz
Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
BJU international 2009;103(12):1632-5.
2009: Claudio Jeldres; Jean-Jacques Patard; umberto capitanio; Paul Perrotte; Nazareno Suardi; Maxime Crepel; Vincenzo Ficarra; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Christian Pfister; Baptiste Albouy; Marc Colombel; Arnaud Méjean; Hervé Lang; Didier Jacqmin; Jean-Christophe Bernhard; Jean-Marie Ferrière; Karim Bensalah; Pierre I Karakiewicz
Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.
Urology 2009;73(6):1300-5.
2009: umberto capitanio; Paul Perrotte; Laurent Zini; Nazareno Suardi; Elie Antebi; Vincent Cloutier; Claudio Jeldres; Shahrokh F Shariat; AJ Duclos; Philippe Arjane; Fred Saad; Francesco Montorsi; Pierre I Karakiewicz
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.
Urology 2009;73(6):1323-7.
2009: Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Nazareno Suardi; Jochen Walz; Claus G Roehrborn; Francesco Montorsi; Kevin Slawin; Shahrokh F Shariat
Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.
The Prostate 2009;69(8):886-94.
2009: umberto capitanio; Vincent Cloutier; Laurent Zini; Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Paul Perrotte; Elie Antebi; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
BJU international 2009;103(11):1496-500.
2009: L Zini; Jean-Jacques Patard; umberto capitanio; Arnaud Mejean; Arnauld Villers; Alexandre de la Taille; Vincenzo Ficarra; M Crepel; R Bertini; Laurent Salomon; Grégory Verhoest; Paul Perrotte; K Bensalah; P Arjane; J Biserte; Francesco Montorsi; Pierre I Karakiewicz
The use of partial nephrectomy in European tertiary care centers.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(6):636-42.
2009: umberto capitanio; Pierre I Karakiewicz; Claudio Jeldres; Alberto Briganti; Andrea Gallina; Nazareno Suardi; Andrea Cestari; Giorgio Guazzoni; Andrea Salonia; Francesco Montorsi
The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted.
International journal of urology : official journal of the Japanese Urological Association 2009;16(5):526-9.
2009: Yair Lotan; umberto capitanio; Shahrokh F Shariat; Georg C Hutterer; Pierre I Karakiewicz
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.
BJU international 2009;103(10):1368-74.
2009: Hendrik Isbarn; Pierre I Karakiewicz
Predicting cancer-control outcomes in patients with renal cell carcinoma.
Current opinion in urology 2009;19(3):247-57.
2009: umberto capitanio; Pierre I Karakiewicz; Luc Valiquette; Paul Perrotte; Claudio Jeldres; Alberto Briganti; Andrea Gallina; Nazareno Suardi; Andrea Cestari; Giorgio Guazzoni; Andrea Salonia; Francesco Montorsi
Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Urology 2009;73(5):1087-91.
2009: umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Yair Lotan; Ganesh S Palapattu; Patrick J Bastian; Amit Gupta; Amnon Vazina; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Pierre I Karakiewicz
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.
BJU international 2009;103(10):1359-62.
2009: Shahrokh F Shariat; Guilherme Godoy; Pierre I Karakiewicz; Seth P Lerner
Use of nomograms for predictions of outcome in patients with advanced bladder cancer.
Therapeutic advances in urology 2009;1(1):13-26.
2009: Laurent Zini; Paul Perrotte; umberto capitanio; Claudio Jeldres; Shahrokh F Shariat; Elie Antebi; Fred Saad; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
Radical versus partial nephrectomy: effect on overall and noncancer mortality.
Cancer 2009;115(7):1465-71.
2009: Laurent Zini; Paul Perrotte; Claudio Jeldres; umberto capitanio; AJ Duclos; Martine Jolivet-Tremblay; Philippe Arjane; François Péloquin; Daniel Pharand; Arnauld Villers; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
BJU international 2009;103(7):899-904; discussion 904.
2009: Laurent Zini; Jean-Jacques Patard; umberto capitanio; Maxime Crepel; Alexandre de la Taille; Jacques Tostain; Vincenzo Ficarra; Jean-Christophe Bernhard; Jean-Marie Ferrière; Christian Pfister; Arnauld Villers; Francesco Montorsi; Pierre I Karakiewicz
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
BJU international 2009;103(7):894-8.
2009: Laurent Zini; Paul Perrotte; umberto capitanio; Claudio Jeldres; AJ Duclos; Philippe Arjane; Arnauld Villers; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Race affects access to nephrectomy but not survival in renal cell carcinoma.
BJU international 2009;103(7):889-93.
2009: Kevin C Zorn; Umberto Capitanio; Claudio Jeldres; Philippe Arjane; Paul Perrotte; Shahrokh F Shariat; David I Lee; Arieh L Shalhav; Gregory P Zagaja; Sergey A Shikanov; Ofer N Gofrit; Alan E Thong; David M Albala; Leon Sun; Pierre I Karakiewicz
Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
International journal of radiation oncology, biology, physics 2009;73(5):1461-7.
2009: Alberto Briganti; Pierre I Karakiewicz; Steven Joniau; Hendrik Van Poppel
Open to debate. The motion: Nomograms should become a routine tool in determining prostate cancer prognosis.
European urology 2009;55(3):743-7.
2009: Christopher R Porter; Umberto Capitanio; Paul Perrotte; Jochen Walz; Hendrik Isbarn; Koichi Kodama; Robert P Gibbons; RJ Correa; Pierre I Karakiewicz
Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study.
BJU international 2009;103(5):597-602.
2009: fianceeyi chun; Nazareno Suardi; umberto capitanio; Claudio Jeldres; Sascha A Ahyai; Markus Graefen; Alexander Haese; Thomas Steuber; Andreas Erbersdobler; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
European urology 2009;55(3):617-28-6.
2009: Claudio Jeldres; Nazareno Suardi; Paul Perrotte; umberto capitanio; Jochen Walz; Georg C Hutterer; Fred Saad; Luc Valiquette; Markus Graefen; Hugues Widmer; Pierre I Karakiewicz
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(1):13-21.
2009: Laurent Zini; Vincent Cloutier; Hendrik Isbarn; Paul Perrotte; umberto capitanio; Claudio Jeldres; Shahrokh F Shariat; Fred Saad; Philippe Arjane; AJ Duclos; Jean-Baptiste Lattouf; Francesco Montorsi; Pierre I Karakiewicz
A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1013-8.
2009: Georg Salomon; Hendrik Isbarn; Lars Budaeus; Thorsten Schlomm; Alberto Briganti; Thomas Steuber; Hans Heinzer; Alexander Haese; Markus Graefen; Pierre I Karakiewicz; Hartwig Huland; fianceeyi chun
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
The journal of sexual medicine 2009;6(2):498-504.
2009: Jochen Walz; Felix K-H Chun; Eric A Klein; Alwyn M Reuther; Fred Saad; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
The Journal of urology 2009;181(2):601-7; discussion 607-8.
2009: Eiji Kikuchi; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Shuji Mikami; Yair Lotan; Mesut Remzi; Christian Bolenz; Cord Langner; Alon Z Weizer; Francesco Montorsi; Karim Bensalah; Theresa Koppie; Mario I Fernández; Jay D Raman; Wassim Kassouf; Christopher G Wood; Nazareno Suardi; Mototsugu Oya; Shahrokh F Shariat
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):612-8.
2009: Laurent Zini; umberto capitanio; Paul Perrotte; Claudio Jeldres; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
Urology 2009;73(2):342-6.
2009: Jochen Walz; fianceeyi chun; Eric A Klein; Alwyn M Reuther; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
European urology 2009;55(2):412-19.
2009: Naeem Bhojani; Laurent Salomon; umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Daniel Pharand; François Péloquin; Philippe Arjane; Claude C Abbou; Alexandre de la Taille; Francesco Montorsi; Pierre I Karakiewicz
External validation of the updated partin tables in a cohort of French and Italian men.
International journal of radiation oncology, biology, physics 2009;73(2):347-52.
2009: Shahrokh F Shariat; Umberto Capitanio; Claudio Jeldres; Pierre I Karakiewicz
Can nomograms be superior to other prediction tools?
BJU international 2009;103(4):492-5; discussion 495-7.
2009: N Bhojani; Sascha A Ahyai; Markus Graefen; umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(2):123-8.
2009: Pierre I Karakiewicz; Nazareno Suardi; umberto capitanio; Claudio Jeldres; Vincenzo Ficarra; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Peter F A Mulders; Karim Bensalah; Walter Artibani; Laurent Salomon; Richard Zigeuner; Antoine Valéri; Jean-Luc Descotes; Jean-Jacques Rambeaud; Arnaud Méjean; Francesco Montorsi; Roberto Bertini; Jean-Jacques Patard
A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma.
European urology 2009;55(2):287-95.
2009: Vitaly Margulis; Yair Lotan; Pierre I Karakiewicz; Yves Fradet; Raheela Ashfaq; Umberto Capitanio; Francesco Montorsi; Patrick J Bastian; Matthew Nielsen; Stefan C Müller; Jérôme Rigaud; Lukas Heukamp; GEORGES NETTO; Seth P Lerner; Arthur I Sagalowsky; Shahrokh F Shariat
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
Journal of the National Cancer Institute 2009;101(2):114-9.
2009: Shahrokh F Shariat; Jose A Karam; Pierre I Karakiewicz
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81.
European urology 2009;55(1):250-2.
2009: umberto capitanio; Paul Perrotte; Georg C Hutterer; Nazareno Suardi; Claudio Jeldres; Shahrokh F Shariat; Alain Duclos; Philippe Arjane; Francesco Montorsi; Pierre I Karakiewicz
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
International journal of urology : official journal of the Japanese Urological Association 2009;16(1):91-5.
2009: Ofer Yossepowitch; Anders Bjartell; James A Eastham; Markus Graefen; Bertrand D Guillonneau; Pierre I Karakiewicz; Rodolfo Montironi; Franceso Montorsi
Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences.
European urology 2009;55(1):87-99.
2009: umberto capitanio; Pierre I Karakiewicz; Claudio Jeldres; Alberto Briganti; Andrea Salonia; Andrea Cestari; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi
Suspected clinical T3 prostate cancer is associated with a high rate of negative extended biopsies: clinical implications.
European urology 2009;55(1):253-4.
2008: Pierre I Karakiewicz; Claudio Jeldres; Nazareno Suardi; Georg C Hutterer; Paul Perrotte; umberto capitanio; Vincenzo Ficarra; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Peter F Mulders; Laurent Salomon; Richard Zigeuner; Luigi Schips; Denis Chautard; Antoine Valeri; Eric Lechevallier; Jean-Luc Descots; Herve Lang; Arnaud Mejean; Gregory Verhoest; Jean-Jacques Patard
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2008;2(6):610-7.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Claus G Roehrborn; Michael W Kattan
An updated catalog of prostate cancer predictive tools.
Cancer 2008;113(11):3075-99.
2008: Laurent Zini; Paul Perrotte; Claudio Jeldres; umberto capitanio; Daniel Pharand; Philippe Arjane; Steven Lapointe; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
BJU international 2008;102(11):1610-4.
2008: umberto capitanio; Sascha A Ahyai; Markus Graefen; Claudio Jeldres; Shahrokh F Shariat; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Paul Perrotte; François Péloquin; Daniel Pharand; Philippe Arjane; Hartwig Huland; Pierre I Karakiewicz
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
Urology 2008;72(6):1208-11; discussion 1212-3.
2008: Claudio Jeldres; Nazareno Suardi; Jochen Walz; Georg C Hutterer; Sascha A Ahyai; Jean-Baptiste Lattouf; Alexander Haese; Markus Graefen; Andreas Erbersdobler; Hans Heinzer; Hartwig Huland; Pierre I Karakiewicz
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
European urology 2008;54(6):1306-13.
2008: Amit Gupta; Pierre I Karakiewicz; Claus G Roehrborn; Yair Lotan; Alexandre R Zlotta; Shahrokh F Shariat
Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7385-90.
2008: Jochen Walz; Alexander Haese; Vincenzo Scattoni; Thomas Steuber; Felix K-H Chun; Alberto Briganti; Francesco Montorsi; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
Cancer 2008;113(10):2695-703.
2008: umberto capitanio; Laurent Zini; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Philippe Arjane; Daniel Pharand; Hugues Widmer; François Péloquin; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
Urology 2008;72(5):1090-5.
2008: Nazareno Suardi; umberto capitanio; Felix K-H Chun; Markus Graefen; Paul Perrotte; Thorsten Schlomm; Alexander Haese; Hartwig Huland; Andreas Erbersdobler; Francesco Montorsi; Pierre I Karakiewicz
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
Cancer 2008;113(8):2068-72.
2008: Shahrokh F Shariat; Christian Bolenz; Pierre I Karakiewicz
Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators.
European urology 2008;54(4):948-9.
2008: umberto capitanio; Alberto Briganti; Shahrokh F Shariat; Pierre I Karakiewicz
The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective.
European urology 2008;54(4):717-9.
2008: Christopher R Porter; Nazareno Suardi; Koichi Kodama; Umberto Capitanio; Robert P Gibbons; Roy Correa; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
A nomogram predicting metastatic progression after radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2008;15(10):889-94.
2008: Alberto Briganti; umberto capitanio; Felix K-H Chun; Andrea Gallina; Nazareno Suardi; Andrea Salonia; Luigi Da Pozzo; Renzo Colombo; Valerio Di Girolamo; Roberto Bertini; Giorgio Guazzoni; Pierre I Karakiewicz; Francesco Montorsi; Patrizio Rigatti
Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
European urology 2008;54(4):794-802.
2008: umberto capitanio; Claudio Jeldres; Shahrokh F Shariat; Pierre I Karakiewicz
Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best.
European urology 2008;54(4):958-9.
2008: Jose A Karam; Vitaly Margulis; Francesco Montorsi; Pierre I Karakiewicz; Yair Lotan; Eiji Kikuchi; Alon Z Weizer; Richard Zigeuner; Christian Bolenz; Shahrokh F Shariat
Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study.
European urology 2008;54(4):961-3.
2008: Pierre I Karakiewicz; Naeem Bhojani; umberto capitanio; Alwyn M Reuther; Nazareno Suardi; Claudio Jeldres; Daniel Pharand; François Péloquin; Paul Perrotte; Shahrokh F Shariat; Eric A Klein
External validation of the updated Partin tables in a cohort of North American men.
The Journal of urology 2008;180(3):898-902; discussion 902-3.
2008: Shahrokh F Shariat; Adam Jenkins; Claus G Roehrborn; Jose A Karam; Key H Stage; Pierre I Karakiewicz
Features and outcomes of patients with grade IV renal injury.
BJU international 2008;102(6):728-33; discussion 733.
2008: Naeem Bhojani; Paul Perrotte; Georg C Hutterer; Nazareno Suardi; Claudio Jeldres; Shahrokh F Shariat; umberto capitanio; Philippe Arjane; Hugues Widmer; Francois Benard; Francois Peloquin; Francesco Montorsi; Pierre I Karakiewicz
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
The journal of sexual medicine 2008;5(9):2141-51.
2008: Felix K-H Chun; Alexander Haese; Sascha A Ahyai; Jochen Walz; Nazareno Suardi; umberto capitanio; Markus Graefen; Andreas Erbersdobler; Hartwig Huland; Pierre I Karakiewicz
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
Cancer 2008;113(4):701-9.
2008: Fred Saad; Dean Ruether; Scott Ernst; Scott North; Tina Cheng; Paul Perrotte; Pierre I Karakiewicz; Eric Winquist
The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone.
BJU international 2008;102(5):551-5.
2008: Andrea Gallina; Pierre I Karakiewicz
Editorial comment on: current applications for prostate-specific antigen doubling time.
European urology 2008;54(2):302.
2008: Felix K-H Chun; Pierre I Karakiewicz; Alberto Briganti
Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone.
European urology 2008;54(2):241-2.
2008: Alberto Briganti; Felix K-H Chun; Pierre I Karakiewicz; Patrizio Rigatti; Francesco Montorsi
Is node-positive prostate cancer always a systemic disease?
European urology 2008;54(2):243-6.
2008: Claudio Jeldres; Nazareno Suardi; umberto capitanio; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Francois Peloquin; Daniel Pharand; Markus Graefen; Pierre I Karakiewicz
High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer.
BJU international 2008;102(4):463-7.
2008: Andrea Gallina; Nazareno Suardi; Francesco Montorsi; umberto capitanio; Claudio Jeldres; Fred Saad; Markus Graefen; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; François Péloquin; Paul Perrotte; Pierre I Karakiewicz
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.
International journal of cancer. Journal international du cancer 2008;123(3):647-52.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Nazareno Suardi; Michael W Kattan
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4400-7.
2008: Jean-Jacques Patard; Patricia Fergelot; Pierre I Karakiewicz; Tobias Klatte; Quoc-Dien Trinh; Nathalie Rioux-Leclercq; Jonathan W Said; Arie S Belldegrun; Allan J Pantuck
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma.
International journal of cancer. Journal international du cancer 2008;123(2):395-400.
2008: Jochen Walz; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Paul Perrotte; Markus Graefen; Hughes Widmer; Philippe Arjane; Luc Valiquette; Georg C Hutterer; Fred Saad; Pierre I Karakiewicz
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
BJU international 2008;102(1):33-8.
2008: Shahrokh F Shariat; Vitaly Margulis; Pierre I Karakiewicz
Rebuttal from authors re: James W.F. Catto. More nomograms or better evidence of efficacy: what do we need in urologic oncology? Eur Urol 2008;54:11-12.
European urology 2008;54(1):13-5.
2008: umberto capitanio; Vincenzo Scattoni; Massimo Freschi; Alberto Briganti; Andrea Salonia; Andrea Gallina; Renzo Colombo; Pierre I Karakiewicz; Patrizio Rigatti; Francesco Montorsi
Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
European urology 2008;54(1):118-25.
2008: Shahrokh F Shariat; Pierre I Karakiewicz
Perspectives on prostate cancer biomarkers.
European urology 2008;54(1):8-10.
2008: Shahrokh F Shariat; Vitaly Margulis; Yair Lotan; Francesco Montorsi; Pierre I Karakiewicz
Nomograms for bladder cancer.
European urology 2008;54(1):41-53.
2008: Claudio Jeldres; Nazareno Suardi; Fred Saad; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Naeem Bhojani; Jochen Walz; Georg C Hutterer; Markus Graefen; Luc Valiquette; Pierre I Karakiewicz
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.
European urology 2008;54(1):97-105.
2008: Claudio Jeldres; Nazareno Suardi; Jochen Walz; Fred Saad; Georg C Hutterer; Naeem Bhojani; Shahrokh F Shariat; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
European urology 2008;54(1):107-16.
2008: Shahrokh F Shariat; Jose A Karam; Jochen Walz; Claus G Roehrborn; Francesco Montorsi; Vitaly Margulis; Fred Saad; Kevin Slawin; Pierre I Karakiewicz
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3785-91.
2008: Shahrokh F Shariat; Quoc-Dien Trinh; Allen F Morey; Key H Stage; Claus G Roehrborn; Luc Valiquette; Pierre I Karakiewicz
Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma.
The Journal of trauma 2008;64(6):1451-8.
2008: Robert S Svatek; Jose A Karam; Claus G Roehrborn; Pierre I Karakiewicz; Kevin Slawin; Shahrokh F Shariat
Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3362-6.
2008: Jochen Walz; Shahrokh F Shariat; Nazareno Suardi; Paul Perrotte; Yair Lotan; Ganesh S Palapattu; Amit Gupta; Patrick J Bastian; Craig G Rogers; Amnon Vazina; Gilad E Amiel; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner; Pierre I Karakiewicz
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
BJU international 2008;101(11):1356-61.
2008: Andrea Gallina; Felix K-H Chun; Nazareno Suardi; James A Eastham; Paul Perrotte; Markus Graefen; Georg C Hutterer; Hartwig Huland; Eric A Klein; Alwyn M Reuther; Francesco Montorsi; Alberto Briganti; Shahrokh F Shariat; Claus G Roehrborn; Alexandre de la Taille; Laurent Salomon; Pierre I Karakiewicz
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU international 2008;101(12):1513-8.
2008: Nazareno Suardi; Vincenzo Scattoni; Alberto Briganti; Andrea Salonia; Richard Naspro; Andrea Gallina; Andrea Cestari; Renzo Colombo; Pierre I Karakiewicz; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi
Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement.
European urology 2008;53(6):1180-5.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Vitaly Margulis; Michael W Kattan
Inventory of prostate cancer predictive tools.
Current opinion in urology 2008;18(3):279-96.
2008: Naeem Bhojani; Claudio Jeldres; Jean-Jacques Patard; Paul Perrotte; Nazareno Suardi; Georg C Hutterer; François Patenaude; Stéphane Oudard; Pierre I Karakiewicz
Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma.
European urology 2008;53(5):917-30.
2008: Pierre I Karakiewicz; Naeem Bhojani; Alfred I Neugut; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; Paul Perrotte; Francois Peloquin; Michael W Kattan
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
The journal of sexual medicine 2008;5(4):919-27.
2008: Jochen Walz; Francesco Montorsi; Claudio Jeldres; Nazareno Suardi; Shahrokh F Shariat; Paul Perrotte; Philippe Arjane; Markus Graefen; Daniel Pharand; Pierre I Karakiewicz
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
BJU international 2008;101(7):826-32.
2008: Shahrokh F Shariat; Jochen Walz; Claus G Roehrborn; Francesco Montorsi; Claudio Jeldres; Fred Saad; Pierre I Karakiewicz
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
The Journal of urology 2008;179(4):1593-7.
2008: Pierre I Karakiewicz; Nazareno Suardi; Shahrokh F Shariat
The search for better prognostic factors for men treated for localized prostate cancer continues.
European urology 2008;53(4):689-90.
2008: Pierre I Karakiewicz; Nazareno Suardi; Claudio Jeldres; Pascale Audet; Pierre Ghosn; Jean-Jacques Patard; Paul Perrotte
Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi.
European urology 2008;53(4):845-8.
2008: Sascha A Ahyai; Markus Graefen; Thomas Steuber; Alexander Haese; Thorsten Schlomm; Jochen Walz; Jens Köllermann; Alberto Briganti; Mario Zacharias; Martin G Friedrich; Pierre I Karakiewicz; Francesco Montorsi; Hartwig Huland; Felix K-H Chun
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
European urology 2008;53(4):750-7.
2008: Shahrokh F Shariat; Jochen Walz; Claus G Roehrborn; Alexandre R Zlotta; Paul Perrotte; Nazareno Suardi; Fred Saad; Pierre I Karakiewicz
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1526-31.
2008: Nazareno Suardi; Christopher R Porter; Alwyn M Reuther; Jochen Walz; Koichi Kodama; Robert P Gibbons; Roy Correa; Francesco Montorsi; Markus Graefen; Hartwig Huland; Eric A Klein; Pierre I Karakiewicz
A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
Cancer 2008;112(6):1254-63.
2008: Pierre I Karakiewicz; Felix K-H Chun; Andrea Gallina; Nazareno Suardi; Alberto Briganti; Andreas Erbersdobler; Thorsten Schlomm; Jochen Walz; Eike Currlin; Uwe Michl; Alexander Haese; Philippe Arjane; Hans Heinzer; Markus Graefen; Hartwig Huland
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
Journal of endourology / Endourological Society 2008;22(3):533-8.
2008: Jose A Karam; Robert S Svatek; Pierre I Karakiewicz; Andrea Gallina; Claus G Roehrborn; Kevin Slawin; Shahrokh F Shariat
Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1418-22.
2008: Georg C Hutterer; Pierre I Karakiewicz; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Paul Perrotte; Yair Lotan; Michael J Marberger; Shahrokh F Shariat
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
BJU international 2008;101(5):561-5.
2008: Naeem Bhojani; Paul Perrotte; Claudio Jeldres; Nazareno Suardi; Georg C Hutterer; Shahrokh F Shariat; Pierre I Karakiewicz
The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
The journal of sexual medicine 2008;5(3):668-76.
2008: Andrea Salonia; Andrea Gallina; Alberto Briganti; Giuseppe Zanni; Antonino Saccà; Federico Dehò; Pierre I Karakiewicz; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi
Remembered International Index of Erectile Function domain scores are not accurate in assessing preoperative potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy.
The journal of sexual medicine 2008;5(3):677-83.
2008: Shahrokh F Shariat; Pierre I Karakiewicz
Screening for prostate cancer in 2007: the PSA era and its challenges are not over.
European urology 2008;53(3):457-60.
2008: Alberto Briganti; Andrea Gallina; Nazareno Suardi; Felix K-H Chun; Jochen Walz; Roman Heuer; Andrea Salonia; Alexander Haese; Paul Perrotte; Luc Valiquette; Markus Graefen; Patrizio Rigatti; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
BJU international 2008;101(5):556-60.
2008: Shahrokh F Shariat; Jose A Karam; Vitaly Margulis; Pierre I Karakiewicz
New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.
BJU international 2008;101(6):675-83.
2008: Pierre I Karakiewicz
Editorial comment on: Prostate cancer characteristics in a multiracial community.
European urology 2008;53(3):539.
2008: Amit Gupta; Yair Lotan; Patrick J Bastian; Ganesh S Palapattu; Pierre I Karakiewicz; Ganesh V Raj; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Shahrokh F Shariat
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
Urology 2008;71(2):302-7.
2008: Jochen Walz; Nazareno Suardi; Georg C Hutterer; Paul Perrotte; Andrea Gallina; Francois Bénard; Luc Valiquette; Michael McCormack; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
Journal of endourology / Endourological Society 2008;22(2):369-76.
2008: Pierre I Karakiewicz; Georg C Hutterer
Predictive models and prostate cancer.
Nature clinical practice. Urology 2008;5(2):82-92.
2008: Jochen Walz; Paul Perrotte; Nazareno Suardi; Georg C Hutterer; Claudio Jeldres; François Bénard; Luc Valiquette; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
The journal of sexual medicine 2008;5(2):428-35.
2008: Robert S Svatek; Jose A Karam; Pierre I Karakiewicz; Andrea Gallina; Roberto Casella; Claus G Roehrborn; Shahrokh F Shariat
Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
The Journal of urology 2008;179(2):478-84; discussion 484.
2008: Patrick J Bastian; Georg C Hutterer; Shahrokh F Shariat; Craig G Rogers; Ganesh S Palapattu; Yair Lotan; Amnon Vazina; Gilad E Amiel; Amit Gupta; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg; Pierre I Karakiewicz
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
BJU international 2008;101(4):450-4.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Raheela Ashfaq; Seth P Lerner; Ganesh S Palapattu; Richard J Cote; Arthur I Sagalowsky; Yair Lotan
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
Cancer 2008;112(2):315-25.
2008: Philippe Gannon; Ismael Hervé Koumakpayi; Cecile Le Page; Pierre I Karakiewicz; Anne-Marie Mes-Masson; Fred Saad
Ebp1 expression in benign and malignant prostate.
Cancer cell international 2008;8():18.
2008: Georg C Hutterer; Jean-Jacques Patard; Claudio Jeldres; Paul Perrotte; Alexandre de la Taille; Laurent Salomon; Grégory Verhoest; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Walter Artibani; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Pierre I Karakiewicz
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram.
BJU international 2008;101(1):39-43.
2008: Shahrokh F Shariat; Robert S Svatek; Wareef Kabbani; Jochen Walz; Yair Lotan; Pierre I Karakiewicz; Claus G Roehrborn
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.
BJU international 2008;101(2):232-7.
2007: Felix K-H Chun; Nazareno Suardi; Paul Perrotte; Thierry Lebeau; Jean-Pierre Guay; Serge Benayoun; Alvaro Ramirez; François Bénard; Michael McCormack; Luc Valiquette; Pierre I Karakiewicz
Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
The Canadian journal of urology 2007;14(6):3727-33.
2007: Alberto Briganti; Felix K-H Chun; Nazareno Suardi; Andrea Gallina; Jochen Walz; Markus Graefen; Shahrokh F Shariat; Andreas Ebersdobler; Patrizio Rigatti; Paul Perrotte; Fred Saad; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Prostate volume and adverse prostate cancer features: fact not artifact.
European journal of cancer (Oxford, England : 1990) 2007;43(18):2669-77.
2007: Jochen Walz; Andrea Gallina; Paul Perrotte; Claudio Jeldres; Quoc-Dien Trinh; Georg C Hutterer; Miriam Traumann; Alvaro Ramirez; Shahrokh F Shariat; Michael McCormack; Jean-Paul Perreault; François Bénard; Luc Valiquette; Fred Saad; Pierre I Karakiewicz
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
BJU international 2007;100(6):1254-8.
2007: Jochen Walz; Paul Perrotte; Georg C Hutterer; Nazareno Suardi; Claudio Jeldres; François Bénard; Luc Valiquette; Pierre I Karakiewicz
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
BJU international 2007;100(6):1307-11.
2007: Georg C Hutterer; Jean-Jacques Patard; Marc Colombel; Arie S Belldegrun; Christian Pfister; Francois Guille; Walter Artibani; Francesco Montorsi; Allan J Pantuck; Pierre I Karakiewicz
Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
Cancer 2007;110(11):2428-33.
2007: Andrea Gallina; Alberto Briganti; Felix K-H Chun; Jochen Walz; Georg C Hutterer; Andreas Erbersdobler; Christian Eichelberg; Thorsten Schlomm; Sascha A Ahyai; Paul Perrotte; Fred Saad; Francesco Montorsi; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
BJU international 2007;100(6):1249-53.
2007: Georg C Hutterer; Jean-Jacques Patard; Paul Perrotte; Constantin Ionescu; Alexandre de la Taille; Laurent Salomon; Grégory Verhoest; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Walter Artibani; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Antoine Valeri; Denis Chautard; Jean-Luc Descotes; Jean-Jacques Rambeaud; Arnaud Mejean; Pierre I Karakiewicz
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram.
International journal of cancer. Journal international du cancer 2007;121(11):2556-61.
2007: Kevin C Zorn; Andrea Gallina; Georg C Hutterer; Jochen Walz; Arieh L Shalhav; Gregory P Zagaja; Luc Valiquette; Ofer N Gofrit; Marcelo A Orvieto; Jerome B Taxy; Pierre I Karakiewicz
External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.
Journal of endourology / Endourological Society 2007;21(11):1345-51.
2007: Matthew Nielsen; Ganesh S Palapattu; Pierre I Karakiewicz; Yair Lotan; Patrick J Bastian; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Shahrokh F Shariat
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
BJU international 2007;100(5):1015-20.
2007: Pierre I Karakiewicz
Editorial comment on: Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
European urology 2007;52(5):1355-6.
2007: Pierre I Karakiewicz; Quoc-Dien Trinh; John S Lam; Jacques Tostain; Allan J Pantuck; Arie S Belldegrun; Jean-Jacques Patard
Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
European urology 2007;52(5):1428-36.
2007: Andrea Gallina; Claudio Jeldres; Felix K-H Chun; Shahrokh F Shariat; Alberto Briganti; Jochen Walz; Claus G Roehrborn; Fred Saad; Hartwig Huland; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
European urology 2007;52(5):1374-80.
2007: Pierre I Karakiewicz; Georg C Hutterer
Predicting outcomes in patients with urologic cancers.
Current opinion in supportive and palliative care 2007;1(3):153-68.
2007: Pierre I Karakiewicz; Georg C Hutterer; Quoc-Dien Trinh; Allan J Pantuck; Tobias Klatte; John S Lam; Francois Guille; Alexandre de la Taille; Giacomo Novara; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Denis Chautard; Eric Lechevallier; Antoine Valeri; Jean-Luc Descotes; Herve Lang; Michel Soulie; Jean-Marie Ferriere; Christian Pfister; Arnaud Mejean; Arie S Belldegrun; Jean-Jacques Patard
Unclassified renal cell carcinoma: an analysis of 85 cases.
BJU international 2007;100(4):802-8.
2007: Shahrokh F Shariat; Sangtae Park; Quoc-Dien Trinh; Claus G Roehrborn; Kevin Slawin; Pierre I Karakiewicz
Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
The Journal of urology 2007;178(4 Pt 1):1229-36; discussion 1236-7.
2007: Felix K-H Chun; Alberto Briganti; Andrea Gallina; Georg C Hutterer; Shahrokh F Shariat; Elie Antebie; Jochen Walz; Claus G Roehrborn; Andrea Salonia; Patrizio Rigatti; Fred Saad; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
European urology 2007;52(4):1067-74.
2007: Pierre I Karakiewicz; Quoc-Dien Trinh; Nathalie Rioux-Leclercq; Alexandre de la Taille; Giacomo Novara; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Walter Artibani; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Eric Lechevallier; Christian Coulange; Antoine Valeri; Jean-Luc Descotes; Jean-Jacques Rambeaud; Claude C Abbou; Herve Lang; Didier Jacqmin; Arnaud Mejean; Jean-Jacques Patard
Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
European urology 2007;52(4):1140-5.
2007: Shahrokh F Shariat; Karim Bensalah; Jose A Karam; Claus G Roehrborn; Andrea Gallina; Yair Lotan; Kevin Slawin; Pierre I Karakiewicz
Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5377-84.
2007: Pierre I Karakiewicz; Georg C Hutterer; Quoc-Dien Trinh; Claudio Jeldres; Paul Perrotte; Andrea Gallina; Jacques Tostain; Jean-Jacques Patard
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
Cancer 2007;110(6):1241-7.
2007: Pierre I Karakiewicz; Georg C Hutterer
Predicting cancer-control outcomes in patients with renal cell carcinoma.
Current opinion in urology 2007;17(5):295-302.
2007: Georg C Hutterer; Pierre I Karakiewicz
Can the AJCC staging system risk-stratify patients with localized prostate cancer?
Nature clinical practice. Urology 2007;4(9):482-3.
2007: Alberto Briganti; Shahrokh F Shariat; Felix K-H Chun; Georg C Hutterer; Claus G Roehrborn; Andrea Gallina; Patrizio Rigatti; Luc Valiquette; Francesco Montorsi; Pierre I Karakiewicz
Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.
BJU international 2007;100(3):528-32.
2007: Jochen Walz; Andrea Gallina; Georg C Hutterer; Paul Perrotte; Shahrokh F Shariat; Markus Graefen; Michael McCormack; François Bénard; Luc Valiquette; Fred Saad; Pierre I Karakiewicz
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2007;69(1):88-94.
2007: Alberto Briganti; Fabio Fabbri; Andrea Salonia; Andrea Gallina; Felix K-H Chun; Federico Dehò; Giuseppe Zanni; Nazareno Suardi; Pierre I Karakiewicz; Patrizio Rigatti; Francesco Montorsi
Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
European urology 2007;52(3):702-7.
2007: Alberto Briganti; Felix K-H Chun; Georg C Hutterer; Andrea Gallina; Shahrokh F Shariat; Andrea Salonia; Vincenzo Scattoni; Luc Valiquette; Francesco Montorsi; Patrizio Rigatti; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
European urology 2007;52(3):733-43.
2007: Jochen Walz; Andrea Gallina; Fred Saad; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; François Bénard; Michael McCormack; Luc Valiquette; Pierre I Karakiewicz
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3576-81.
2007: Andrea Gallina; Pierre I Karakiewicz; Georg C Hutterer; Felix K-H Chun; Alberto Briganti; Jochen Walz; Elie Antebi; Shahrokh F Shariat; Nazareno Suardi; Markus Graefen; Andreas Erbersdobler; Andrea Salonia; Patrizio Rigatti; Hartwig Huland; Francesco Montorsi
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
International journal of cancer. Journal international du cancer 2007;121(4):791-5.
2007: Christopher R Porter; Andrea Gallina; Koichi Kodama; Robert P Gibbons; Roy Correa; Paul Perrotte; Pierre I Karakiewicz
Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy.
European urology 2007;52(2):446-52.
2007: Felix K-H Chun; Alberto Briganti; Markus Graefen; Francesco Montorsi; Christopher Porter; Vincenzo Scattoni; Andrea Gallina; Jochen Walz; Alexander Haese; Thomas Steuber; Andreas Erbersdobler; Thorsten Schlomm; Sascha A Ahyai; Eike Currlin; Luc Valiquette; Hans Heinzer; Patrizio Rigatti; Hartwig Huland; Pierre I Karakiewicz
Development and external validation of an extended 10-core biopsy nomogram.
European urology 2007;52(2):436-44.
2007: Jochen Walz; Paul Perrotte; Andrea Gallina; François Bénard; Luc Valiquette; Michael McCormack; Francesco Montorsi; Pierre I Karakiewicz
Ejaculatory disorders may affect screening for prostate cancer.
The Journal of urology 2007;178(1):232-7; discussion 237-8.
2007: Felix K-H Chun; Georg C Hutterer; Paul Perrotte; Andrea Gallina; Luc Valiquette; Francois Benard; Michael McCormack; Alberto Briganti; Constantin Ionescu; Claudio Jeldres; Jean-Pierre Guay; Fred Saad; Pierre I Karakiewicz
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
BJU international 2007;100(1):37-41.
2007: Andrea Gallina; Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Francesco Montorsi; Andrea Salonia; Andreas Erbersdobler; Patrizio Rigatti; Luc Valiquette; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
European urology 2007;52(1):98-105.
2007: Andrea Gallina; Pierre I Karakiewicz; Felix K-H Chun; Alberto Briganti; Markus Graefen; Francesco Montorsi; Jochen Walz; Claudio Jeldres; Andreas Erbersdobler; Andrea Salonia; Nazareno Suardi; Federico Dehò; Thorsten Schlomm; Vincenzo Scattoni; Alexander Haese; Hans Heinzer; Luc Valiquette; Patrizio Rigatti; Hartwig Huland
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
BJU international 2007;99(6):1404-8.
2007: Alberto Briganti; Pierre I Karakiewicz; Felix K-H Chun; Andrea Gallina; Andrea Salonia; Giuseppe Zanni; Luc Valiquette; Markus Graefen; Hartwig Huland; Patrizio Rigatti; Francesco Montorsi
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
European urology 2007;51(6):1573-81.
2007: Pierre I Karakiewicz; Paul Perrotte; Quoc-Dien Trinh; Jean-Jacques Patard
Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8.
European urology 2007;51(6):1478-80.
2007: Pierre I Karakiewicz; Quoc-Dien Trinh; Naeem Bhojani; Karim Bensalah; Laurent Salomon; Alexandre de la Taille; Jacques Tostain; Luca Cindolo; Vincenzo Altieri; Vincenzo Ficarra; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Antoine Valeri; Jean-Luc Descotes; Arnaud Mejean; Jean-Jacques Patard
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
European urology 2007;51(6):1616-24.
2007: Quoc-Dien Trinh; Etienne Cardinal; Andrea Gallina; Paul Perrotte; Fred Saad; Pierre I Karakiewicz
Sunitinib relieves renal cell carcinoma spinal cord compression.
European urology 2007;51(6):1741-3.
2007: Jose A Karam; Yair Lotan; Claus G Roehrborn; Raheela Ashfaq; Pierre I Karakiewicz; Shahrokh F Shariat
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.
The Prostate 2007;67(6):614-22.
2007: Georg C Hutterer; Paul Perrotte; Andrea Gallina; Jochen Walz; Claudio Jeldres; Miriam Traumann; Nazareno Suardi; Fred Saad; François Bénard; Luc Valiquette; Michael McCormack; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
European journal of cancer (Oxford, England : 1990) 2007;43(7):1180-7.
2007: Felix K-H Chun; Markus Graefen; Alberto Briganti; Andrea Gallina; Julia Hopp; Michael W Kattan; Hartwig Huland; Pierre I Karakiewicz
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
European urology 2007;51(5):1236-40; discussion 1241-3.
2007: Pierre I Karakiewicz; Alberto Briganti; Felix K-H Chun; Quoc-Dien Trinh; Paul Perrotte; Vincenzo Ficarra; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Peter F A Mulders; Laurent Salomon; Richard Zigeuner; Tommaso Prayer-Galetti; Denis Chautard; Antoine Valeri; Eric Lechevallier; Jean-Luc Descotes; Herve Lang; Arnaud Mejean; Jean-Jacques Patard
Multi-institutional validation of a new renal cancer-specific survival nomogram.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1316-22.
2007: Shahrokh F Shariat; Claus G Roehrborn; Pierre I Karakiewicz; Gurleen Dhami; Key H Stage
Evidence-based validation of the predictive value of the American Association for the Surgery of Trauma kidney injury scale.
The Journal of trauma 2007;62(4):933-9.
2007: Felix K-H Chun; Pierre I Karakiewicz; Alberto Briganti; Jochen Walz; Michael W Kattan; Hartwig Huland; Markus Graefen
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
BJU international 2007;99(4):794-800.
2007: Pierre I Karakiewicz; Quoc-Dien Trinh; Alexandre de la Taille; Claude C Abbou; Laurent Salomon; Jacques Tostain; Luca Cindolo; Walter Artibani; Vincenzo Ficarra; Jean-Jacques Patard
ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival.
European journal of cancer (Oxford, England : 1990) 2007;43(6):1023-9.
2007: Alberto Briganti; Andrea Salonia; Andrea Gallina; Felix K-H Chun; Pierre I Karakiewicz; Markus Graefen; Hartwig Huland; Patrizio Rigatti; Francesco Montorsi
Management of erectile dysfunction after radical prostatectomy in 2007.
World journal of urology 2007;25(2):143-8.
2007: Felix K-H Chun; Pierre I Karakiewicz; Hartwig Huland; Markus Graefen
Role of nomograms for prostate cancer in 2007.
World journal of urology 2007;25(2):131-42.
2007: Felix K-H Chun; Alberto Briganti; Claudio Jeldres; Andreas Erbersdobler; Thorsten Schlomm; Thomas Steuber; Andrea Gallina; Jochen Walz; Paul Perrotte; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
European urology 2007;51(4):949-55; discussion 955.
2007: Shahrokh F Shariat; Raheela Ashfaq; Pierre I Karakiewicz; Osamah Saeedi; Arthur I Sagalowsky; Yair Lotan
Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
Cancer 2007;109(6):1106-13.
2007: Pierre I Karakiewicz; Serge Benayoun; Louis R Bégin; AJ Duclos; Luc Valiquette; Michael McCormack; François Bénard; Fred Saad; Paul Perrotte
Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
International journal of clinical practice 2007;61(3):425-30.
2007: Nathalie Rioux-Leclercq; Pierre I Karakiewicz; Quoc-Dien Trinh; Vincenzo Ficarra; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Richard Zigeuner; Arnaud Mejean; Jean-Jacques Patard
Prognostic ability of simplified nuclear grading of renal cell carcinoma.
Cancer 2007;109(5):868-74.
2007: Matthew Nielsen; Shahrokh F Shariat; Pierre I Karakiewicz; Yair Lotan; Craig G Rogers; Gilad E Amiel; Patrick J Bastian; Amnon Vazina; Amit Gupta; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ganesh S Palapattu
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.
European urology 2007;51(3):699-706; discussion 706-8.
2007: Jose A Karam; Yair Lotan; Pierre I Karakiewicz; Raheela Ashfaq; Arthur I Sagalowsky; Claus G Roehrborn; Shahrokh F Shariat
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
The lancet oncology 2007;8(2):128-36.
2007: Felix K-H Chun; Alberto Briganti; Markus Graefen; Christopher Porter; Francesco Montorsi; Alexander Haese; Vincenzo Scattoni; Lester Borden; Thomas Steuber; Andrea Salonia; Thorsten Schlomm; Kalyan Latchemsetty; Jochen Walz; Jason Kim; Christian Eichelberg; Eike Currlin; Sascha A Ahyai; Andreas Erbersdobler; Luc Valiquette; Hans Heinzer; Patrizio Rigatti; Hartwig Huland; Pierre I Karakiewicz
Development and external validation of an extended repeat biopsy nomogram.
The Journal of urology 2007;177(2):510-5.
2007: Felix K-H Chun; Alberto Briganti; Claudio Jeldres; Andrea Gallina; Andreas Erbersdobler; Thorsten Schlomm; Jochen Walz; Christian Eichelberg; Georg Salomon; Alexander Haese; Eike Currlin; Sascha A Ahyai; François Bénard; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
European journal of cancer (Oxford, England : 1990) 2007;43(3):536-43.
2007: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Andrea Gallina; Giuseppe Zanni; Vincenzo Scattoni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
Urology 2007;69(1):147-51.
2007: Felix K-H Chun; Alberto Briganti; Markus Graefen; Andreas Erbersdobler; Jochen Walz; Thorsten Schlomm; Mirja Meschke; Alexander Haese; Luc Valiquette; Hartwig Huland; Pierre I Karakiewicz
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
European journal of cancer (Oxford, England : 1990) 2007;43(2):375-82.
2007: Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
European urology 2007;51(1):152-60.
2007: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Andrea Gallina; Federico Dehò; Nazareno Suardi; Luigi Da Pozzo; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer.
European urology 2007;51(1):112-9; discussion 119-20.
2007: Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
European urology 2007;51(1):137-49; discussion 149-51.
2006: Thomas Steuber; Felix K-H Chun; Andreas Erbersdobler; Alberto Briganti; Alexander Haese; Markus Graefen; Thorsten Schlomm; Luc Valiquette; Hartwig Huland; Pierre I Karakiewicz
Development and internal validation of preoperative transition zone prostate cancer nomogram.
Urology 2006;68(6):1295-300.
2006: Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
The Journal of urology 2006;176(6 Pt 1):2414-22; discussion 2422.
2006: Felix K-H Chun; Alberto Briganti; Elie Antebi; Markus Graefen; Eike Currlin; Thomas Steuber; Thorsten Schlomm; Jochen Walz; Alexander Haese; Martin G Friedrich; Sascha A Ahyai; Christian Eichelberg; Georg Salomon; Andrea Gallina; Andreas Erbersdobler; Paul Perrotte; Hans Heinzer; Hartwig Huland; Pierre I Karakiewicz
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
BJU international 2006;98(6):1204-9.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Paul Perrotte; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Precystectomy nomogram for prediction of advanced bladder cancer stage.
European urology 2006;50(6):1254-60; discussion 1261-2.
2006: Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Gilad E Amiel; Yair Lotan; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Amit Gupta; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6663-76.
2006: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Nazareno Suardi; Andrea Gallina; Luigi Da Pozzo; Marco Roscigno; Giuseppe Zanni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.
European urology 2006;50(5):1006-13.
2006: Felix K-H Chun; Pierre I Karakiewicz; Alberto Briganti; Andrea Gallina; Michael W Kattan; Francesco Montorsi; Hartwig Huland; Markus Graefen
Prostate cancer nomograms: an update.
European urology 2006;50(5):914-26; discussion 926.
2006: Laurent Lessard; Pierre I Karakiewicz; Pascale Bellon-Gagnon; Mona Alam Fahmy; Hazem A Ismail; Anne-Marie Mes-Masson; Fred Saad
Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5741-5.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Amiel E Gilad; Yair Lotan; Craig G Rogers; Amnon Vazina; Amit Gupta; Patrick J Bastian; Paul Perrotte; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
The Journal of urology 2006;176(4 Pt 1):1354-61; discussion 1361-2.
2006: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Andrea Gallina; Elena Farina; Luigi Da Pozzo; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
BJU international 2006;98(4):788-93.
2006: Shahrokh F Shariat; Ganesh S Palapattu; Gilad E Amiel; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.
Urology 2006;68(3):538-42.
2006: Felix K-H Chun; Imke Müller; Imke Lange; Martin G Friedrich; Andreas Erbersdobler; Pierre I Karakiewicz; Markus Graefen; Klaus Pantel; Hartwig Huland; Heidi Schwarzenbach
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.
BJU international 2006;98(3):544-8.
2006: Shahrokh F Shariat; Michael Marberger; Yair Lotan; Marta Sanchez-Carbayo; Craig D Zippe; Gerson Lüdecke; Hans Boman; Ihor S Sawczuk; Martin G Friedrich; Roberto Casella; Christine Mian; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Rupesh Raina; Naoto Miyanaga; Arthur I Sagalowsky; Claus G Roehrborn; Pierre I Karakiewicz
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
The Journal of urology 2006;176(3):919-26; discussion 926.
2006: Jochen Walz; Markus Graefen; Felix K-H Chun; Andreas Erbersdobler; Alexander Haese; Thomas Steuber; Thorsten Schlomm; Hartwig Huland; Pierre I Karakiewicz
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
European urology 2006;50(3):498-505.
2006: Pierre I Karakiewicz; Daniel J Lewinshtein; Felix K-H Chun; Alberto Briganti; Francois Guille; Paul Perrotte; Bernard Lobel; Vincenzo Ficarra; Walter Artibani; Luca Cindolo; Jacques Tostain; Claude C Abbou; Dominique Chopin; Alexandre de la Taille; Jean-Jacques Patard
Tumor size improves the accuracy of TNM predictions in patients with renal cancer.
European urology 2006;50(3):521-8; discussion 529.
2006: Pierre I Karakiewicz; Serge Benayoun; Daniel J Lewinshtein; Felix K-H Chun; Khaled Shahrour; Paul Perrotte
Treatment of BCG failures with intravesical BCG/Interferon: the University of Montreal experience.
The Canadian journal of urology 2006;13(4):3189-94.
2006: Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Markus Graefen; Francesco Montorsi; Andreas Erbersdobler; Thomas Steuber; Andrea Salonia; Eike Currlin; Vincenzo Scattoni; Martin G Friedrich; Thorsten Schlomm; Alexander Haese; Uwe Michl; Renzo Colombo; Hans Heinzer; Luc Valiquette; Patrizio Rigatti; Claus G Roehrborn; Hartwig Huland; Pierre I Karakiewicz
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
BJU international 2006;98(2):329-34.
2006: Christopher R Porter; Koichi Kodama; Robert P Gibbons; Roy Correa; Felix K-H Chun; Paul Perrotte; Pierre I Karakiewicz
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.
The Journal of urology 2006;176(2):569-74.
2006: Pierre I Karakiewicz; Alberto Briganti; Felix K-H Chun; Luc Valiquette
Outcomes research: a methodologic review.
European urology 2006;50(2):218-24.
2006: Felix K-H Chun; Markus Graefen; Mario Zacharias; Alexander Haese; Thomas Steuber; Thorsten Schlomm; Jochen Walz; Pierre I Karakiewicz; Hartwig Huland
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
World journal of urology 2006;24(3):273-80.
2006: Felix K-H Chun; Paul Perrotte; Alberto Briganti; Serge Benayoun; Thierry Lebeau; Alvaro Ramirez; Daniel J Lewinshtein; Luc Valiquette; Jean-Pierre Guay; Pierre I Karakiewicz
Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
BJU international 2006;98(1):50-3.
2006: Alvaro Ramirez; Serge Benayoun; Alberto Briganti; Jongi Chun; Paul Perrotte; Michael W Kattan; Markus Graefen; Michael McCormack; Alfred I Neugut; Fred Saad; Pierre I Karakiewicz
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges.
European urology 2006;50(1):58-62; discussion 62-3.
2006: Craig G Rogers; Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Yair Lotan; Amit Gupta; Amnon Vazina; Amiel Gilad; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
The Journal of urology 2006;175(6):2048-53; discussion 2053.
2006: Daniel J Lewinshtein; Paul Perrotte; Thierry Lebeau; Alvaro Ramirez; Serge Benayoun; Pierre I Karakiewicz
Normal urinary and sexual function in men without evidence of prostate cancer from Montreal, Canada.
BJU international 2006;97(6):1273-7.
2006: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Vincenzo Scattoni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.
European urology 2006;49(6):1019-26; discussion 1026-7.
2006: Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad E Amiel; Yair Lotan; Amnon Vazina; Amit Gupta; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
The Journal of urology 2006;175(5):1645-9; discussion 1649.
2006: Pierre I Karakiewicz; Serge Benayoun; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Michael Marberger; Shahrokh F Shariat
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
BJU international 2006;97(5):997-1001.
2006: Felix K-H Chun; Thomas Steuber; Andreas Erbersdobler; Eike Currlin; Jochen Walz; Thorsten Schlomm; Alexander Haese; Hans Heinzer; Michael McCormack; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
European urology 2006;49(5):820-6.
2006: Fred Saad; Abdulhadi Al Dejmah; Paul Perrotte; Michael McCormack; François Bénard; Luc Valiquette; Pierre I Karakiewicz
Therapeutic approach to hormone-refractory prostate cancer.
The Canadian journal of urology 2006;13 Suppl 2():52-6.
2006: Pierre I Karakiewicz; Felix K-H Chun; Alberto Briganti; Paul Perrotte; Michael McCormack; François Bénard; Luc Valiquette; Markus Graefen; Fred Saad
Prostate cancer nomograms are superior to neural networks.
The Canadian journal of urology 2006;13 Suppl 2():18-25.
2006: Robert S Svatek; Pierre I Karakiewicz; Michael J Shulman; Jose A Karam; Paul Perrotte; Elie A Benaim
Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.
European urology 2006;49(4):666-74.
2006: Thomas Steuber; Markus Graefen; Alexander Haese; Andreas Erbersdobler; Felix K-H Chun; Thorsten Schlom; Paul Perrotte; Hartwig Huland; Pierre I Karakiewicz
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
The Journal of urology 2006;175(3 Pt 1):939-44; discussion 944.
2006: Thomas Steuber; Andreas Erbersdobler; Markus Graefen; Alexander Haese; Hartwig Huland; Pierre I Karakiewicz
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
Cancer 2006;106(4):775-82.
2006: Daniel J Lewinshtein; Michael McCormack; François Péloquin; M Poljicak; Pierre I Karakiewicz; Fred Saad
Recto-cavernosal fistula after radiation for rectal cancer.
The Canadian journal of urology 2006;13(1):2988-9.
2006: Felix K-H Chun; Alberto Briganti; Thierry Lebeau; Vincent Fradet; Thomas Steuber; Jochen Walz; Thorsten Schlomm; Christian Eichelberg; Alexander Haese; Andreas Erbersdobler; Michael McCormack; Paul Perrotte; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.
European urology 2006;49(2):273-8; discussion 278-9.
2006: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Federico Dehò; Luigi Barbieri; Pierre I Karakiewicz; Patrizio Rigatti; Francesco Montorsi
A comparative review of apomorphine formulations for erectile dysfunction : recommendations for use in the elderly.
Drugs & aging 2006;23(4):309-19.
2005: Vincent Fradet; Michael McCormack; Paul Perrotte; Pierre I Karakiewicz; Fred Saad
An epidural abscess following transrectal ultrasound-guided biopsies of the prostate.
The Canadian journal of urology 2005;12(6):2899-900.
2005: Thierry Lebeau; Paul Perrotte; Luc Valiquette; François Bénard; Michael McCormack; Fred Saad; Pierre I Karakiewicz
Validation of prostate cancer index and SF-12 short forms.
The Canadian journal of urology 2005;12(6):2873-9.
2005: Pierre I Karakiewicz; James A Eastham; Markus Graefen; Ilias Cagiannos; Phillip D Stricker; Eric Klein; Thomas Cangiano; Fritz H Schröder; Peter T Scardino; Michael W Kattan
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.
Urology 2005;66(6):1245-50.
2005: Pierre I Karakiewicz; Paul Perrotte; Luc Valiquette; Francois Benard; Michael McCormack; C Menard; M McNaughton Collins; J C Nickel
French-Canadian linguistic validation of the NIH Chronic Prostatitis Symptom Index.
The Canadian journal of urology 2005;12(5):2816-23.
2005: Yair Lotan; Amit Gupta; Shahrokh F Shariat; Ganesh S Palapattu; Amnon Vazina; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad E Amiel; Paul Perotte; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6533-9.
2005: Fred Saad; Paul Perrotte; François Bénard; Michael McCormack; Pierre I Karakiewicz
Bone health in men with prostate cancer: diagnostic and therapeutic considerations.
The Canadian journal of urology 2005;12 Suppl 2():9-15.
2005: Pierre I Karakiewicz; Paul Perrotte; Mike McCormack; François Peloquin; Jean-Paul Perreault; Philippe Arjane; Hughes Widmer; Fred Saad
Early detection of prostate cancer with ultrasound-guided systematic needle biopsy.
The Canadian journal of urology 2005;12 Suppl 2():5-8.
2005: Pierre I Karakiewicz; Serge Benayoun; Michael W Kattan; Paul Perrotte; Luc Valiquette; Peter T Scardino; Ilias Cagiannos; Hans Heinzer; Simon Tanguay; Armen G Aprikian; Hartwig Huland; Markus Graefen
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
The Journal of urology 2005;173(6):1930-4.
2005: Shahrokh F Shariat; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Ihor S Sawczuk; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Frank H Wians; Claus G Roehrborn; Yair Lotan; Paul Perrotte; Serge Benayoun; Michael Marberger; Pierre I Karakiewicz
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
The Journal of urology 2005;173(5):1518-25.
2005: Pierre I Karakiewicz; Jean-Baptiste Lattouf; Paul Perrotte; Luc Valiquette; François Bénard; Michael McCormack; Catherine Ménard; Thierry Lebeau; Serge Benayoun; Alvaro Ramirez; Simon Ouaknine; Fred Saad
Validation of 1997 Partin Tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal Quebec.
The Canadian journal of urology 2005;12(2):2588-92.
2005: Thomas Steuber; Pierre I Karakiewicz; Herbert Augustin; Andreas Erbersdobler; Imke Lange; Alexander Haese; K-H F Chun; Jochen Walz; Markus Graefen; Hartwig Huland
Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
The Journal of urology 2005;173(3):737-41.
2005: Alvaro Ramirez; Paul Perrotte; Luc Valiquette; Francois Benard; Michael McCormack; Fred Saad; Caroline Fournier; Shahrokh F Shariat; Pierre I Karakiewicz
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients.
The Canadian journal of urology 2005;12(1):2537-42.
2005: Fred Saad; Pierre I Karakiewicz; Paul Perrotte
The role of bisphosphonates in hormone-refractory prostate cancer.
World journal of urology 2005;23(1):14-8.
2005: Pierre I Karakiewicz; Shahrokh F Shariat; Amir Naderi; Dov Kadmon; Kevin Slawin
Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.
Urology 2005;65(1):131-5.
2004: Vincent Fradet; Laurent Lessard; Louis R Bégin; Pierre I Karakiewicz; Anne-Marie Mes Masson; Fred Saad
Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8460-4.
2004: Pierre I Karakiewicz; Simon Tanguay; Michael W Kattan; Mostafa Elhilali; Armen G Aprikian
Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men.
European urology 2004;46(2):188-94.
2004: Herb Singh; Pierre I Karakiewicz; Shahrokh F Shariat; Eduardo I Canto; Rahul K Nath; Michael W Kattan; Kevin Slawin
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy.
Urology 2004;63(6):1122-7.
2004: Robert Sabbagh; Michael McCormack; François Péloquin; Raymond Faucher; Jean-Paul Perreault; Paul Perrotte; Pierre I Karakiewicz; Fred Saad
A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy.
The Canadian journal of urology 2004;11(2):2216-9.
2004: Ilias Cagiannos; Pierre I Karakiewicz; Markus Graefen; James A Eastham; Makoto Ohori; Farhang Rabbani; Victor E Reuter; Thomas Wheeler; Patrick A Kupelian; Eric Klein; Hartwig Huland; Peter Hammerer; Andreas Erbersdobler; Fritz Schroeder; Mark F Wildhagen; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
The Journal of urology 2004;171(2 Pt 1):692-6.
2004: Markus Graefen; Makoto Ohori; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Rolf-Peter Henke; Hartwig Huland; Thomas M Wheeler; Kevin Slawin; Peter T Scardino; Michael W Kattan
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
The Journal of urology 2004;171(1):200-3.
2004: Herbert Augustin; Thilo Eggert; Sven Wenske; Pierre I Karakiewicz; Jüri Palisaar; Fedor Daghofer; Hartwig Huland; Markus Graefen
Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.
The Journal of urology 2004;171(1):177-81.
2003: Ilias Cagiannos; Pierre I Karakiewicz; James A Eastham; Makoto Ohori; Farhang Rabbani; Claudia Gerigk; Victor E Reuter; Markus Graefen; Peter Hammerer; Andreas Erbersdobler; Hartwig Huland; Patrick A Kupelian; Eric Klein; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
The Journal of urology 2003;170(5):1798-803.
2003: Sero Andonian; Pierre I Karakiewicz; Harry W Herr
Presacral cystic schwannoma in a man.
Urology 2003;62(3):551.
2003: Michael Aleman; Pierre I Karakiewicz; Patrick A Kupelian; Michael W Kattan; Markus Graefen; Ilias Cagiannos; James A Eastham; Peter T Scardino; Hartwig Huland; Eric A Klein
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
Urology 2003;62(1):70-4.
2003: Pierre I Karakiewicz; Michael W Kattan; Simon Tanguay; Mostafa Elhilali; Michel Bazinet; Peter T Scardino; Armen G Aprikian
Cross-cultural validation of the UCLA prostate cancer index.
Urology 2003;61(2):302-7.
2003: Phillip L Ross; Benjamin Littenberg; Paul Fearn; Peter T Scardino; Pierre I Karakiewicz; Michael W Kattan
Paper standard gamble: a paper-based measure of standard gamble utility for current health.
International journal of technology assessment in health care 2003;19(1):135-47.
2003: Markus Graefen; Herbert Augustin; Pierre I Karakiewicz; Peter Hammerer; Alexander Haese; Jüri Palisaar; Jakob Blonski; Salvador Fernandez; Andreas Erbersdobler; Hartwig Huland
Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.
European urology 2003;43(1):6-10; discussion 11.
2003: Pierre I Karakiewicz; William D Foulkes; Simon Tanguay; Mostafa Elhilali; Armen G Aprikian
Familial prostate and breast cancer in men treated with prostatectomy for prostate cancer: a population based case-control study.
The Journal of urology 2003;169(1):240-4.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Eric Klein; Patrick A Kupelian; Donald G Skinner; Gary Lieskovsky; Bernard H Bochner; Hartwig Huland; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; James A Eastham; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Theo Van der Kwast; Peter T Scardino; Michael W Kattan
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3206-12.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Jüri Palisaar; Salvador Fernandez; Jochen Noldus; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Urologic oncology 2002;7(4):141-6.
2002: Ilias Cagiannos; Markus Graefen; Pierre I Karakiewicz; Makoto Ohori; James A Eastham; Farhang Rabbani; William Fair; Thomas M Wheeler; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2025-30.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Jüri Palisaar; Edith Huland; Peter T Scardino; Michael W Kattan; Hartwig Huland
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
The Journal of urology 2002;167(3):1306-9.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Eric Klein; Patrick A Kupelian; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Peter T Scardino; Michael W Kattan
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):951-6.
2002: R Jüri Palisaar; Markus Graefen; Pierre I Karakiewicz; Peter Hammerer; Edith Huland; Alexander Haese; Salvador Fernandez; Andreas Erbersdobler; Rolf-Peter Henke; Hartwig Huland
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.
European urology 2002;41(2):155-61.
2002: Simon Tanguay; Louis R Bégin; Mostafa Elhilali; Hassan Behlouli; Pierre I Karakiewicz; Armen G Aprikian
Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection.
Urology 2002;59(2):261-5.
1998: Pierre I Karakiewicz; Michel Bazinet; Armen G Aprikian; Simon Tanguay; Mostafa Elhilali
Thirty-day mortality rates and cumulative survival after radical retropubic prostatectomy.
Urology 1998;52(6):1041-6.
1998: Pierre I Karakiewicz; Armen G Aprikian
Prostate cancer: 5. Diagnostic tools for early detection.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1998;159(9):1139-46.
1998: Pierre I Karakiewicz; Armand Zini; A W Meshref; Michel Bazinet; Armen G Aprikian; Mostafa Elhilali
Population-based patterns of radical retropubic prostatectomy use.
Urology 1998;52(2):219-23.
1998: Pierre I Karakiewicz; J A Hanley; Michel Bazinet
Three-dimensional computer-assisted analysis of sector biopsy of the prostate.
Urology 1998;52(2):208-12.
1997: Pierre I Karakiewicz; Armen G Aprikian; Michel Bazinet; Mostafa Elhilali
Patient attitudes regarding treatment-related erectile dysfunction at time of early detection of prostate cancer.
Urology 1997;50(5):704-9.
1997: Michel Bazinet; W Zheng; Louis R Bégin; Armen G Aprikian; Pierre I Karakiewicz; Mostafa Elhilali
Morphologic changes induced by neoadjuvant androgen ablation may result in underdetection of positive surgical margins and capsular involvement by prostatic adenocarcinoma.
Urology 1997;49(5):721-5.
1997: Pierre I Karakiewicz; Michel Bazinet; Armen G Aprikian; C Trudel; S Aronson; M Nachabé; F Péloquint; J Dessureault; M S Goyal; Louis R Bégin; Mostafa Elhilali
Outcome of sextant biopsy according to gland volume.
Urology 1997;49(1):55-9.
1996: Pierre I Karakiewicz; Armen G Aprikian; A W Meshref; Michel Bazinet
Computer-assisted comparative analysis of four-sector and six-sector biopsies of the prostate.
Urology 1996;48(5):747-50.
1996: Pierre I Karakiewicz; Michel Bazinet; P Zvara; Louis R Begin; Gerald B Brock
Blunt cavernous nerve injury: A new animal model mimicking postradical prostatectomy neurogenic impotence.
Urologic oncology 1996;2(5):158-62.
1996: Michel Bazinet; Pierre I Karakiewicz; Armen G Aprikian; C Trudel; F Péloquin; J Dessureault; M Goyal; Louis R Bégin; Mostafa Elhilali
Reassessment of nonplanimetric transrectal ultrasound prostate volume estimates.
Urology 1996;47(6):857-62.
1996: Michel Bazinet; Pierre I Karakiewicz; Armen G Aprikian; C Trudel; S Aronson; F Péloquin; J Dessureault; M S Goyal; W Zheng; Louis R Bégin; M M Elhilali
Complications of ultrasound-guided prostate biopsy peripheral zone only versus combined peripheral and transition zone biopsy.
Urologic oncology 1996;2(2):65-9.
1996: Michel Bazinet; Pierre I Karakiewicz; Armen G Aprikian; C Trudel; S Aronson; M Nachabé; F Péloquin; J Dessureault; M Goyal; W Zheng; Louis R Bégin; Mostafa Elhilali
Value of systematic transition zone biopsies in the early detection of prostate cancer.
The Journal of urology 1996;155(2):605-6.